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Abstract
A colorimetric microassay for protein glycation based oh the periodate 
method has been developed. This microassay has improved sensitivity, 
speed and yield of chromophore enabling it to be used on 0.1 mg aliquots of 
intact protein. However this assay is unsuitable for collagen and so a 
second microassay based on the TBA method was developed. This TBA 
microassay has an improved yield of HMF, is less cumbersome, requires 
less protein than earlier versions, and is suitable as a rapid assay for 
glycated collagen.
Fructation induces AGE formation considerably faster than glucation in vitro 
probably because of the highly reactive fructose-derived aldehydic AP. 
However glycation assays designed for the glucose-AP (a ketose) were 
found to underestirnate the true extent of fructation. For this reason a 
microassay based on the DNPH method was developed to quantify 
fructation.
Comparative rates of protein fluorescence generated by different sugars 
were identical to their comparative rates of SB formation but not 
crosslinking. Using model proteins and different sugars, this study has 
revealed that fluorescent-AGE and crosslinked-AGE may be formed by 
independent pathways ie some proteins are more susceptible to 
crosslinked-AGE and vice versa. Phosphate, pH and calcium have been 
found to increase glucose and fructose-derived fluorescent-AGE in BSA.
Contrary to current dogma, no evidence for an accelerated rise in AGE 
levels in reincubated proteins after removal of free sugars was found. Only 
a small increase in fluorescence of ré incubated glucated-BSA but not 
fructated-BSA was detectable. These studies suggest that free sugars have 
a significant role in fluorescence generation and indeed using chemicaly 
modified proteins, evidence has been presented for a reaction between the
AP and free sugars to form fluorescent products. This secondary glycation is 
more pronounced for fructose and explains in part the higher fluorescence 
generated by fructated proteins.
Comparative studies between inhibitors with different modes of action have 
revealed that aminoguanidine is the most effective at reducing fluorescence 
and crosslinking of proteins in vitro on a molar basis. This is probably 
because the compound has multiple sites of action and more than one 
amino group. Phenylenediamine reacts with 3-DG preventing formation of 
AGE and was found to have a greater inhibitory effect on fructose compared 
to glucose-derived AGE.
In this study, no evidence was found for sugar-induced protein 
fragmentation in vitro unless transition metals were included. Furthermore 
binding of the transition metal to protein appears to be important for 
significant fragmentation to occur and in vivo this autoxidative glycation may 
be restricted to the limited number of copper binding proteins only.
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CHAPTER 1
Introduction
Incubating proteins with reducing sugars for prolonged periods of time 
results in the solution becoming yellow brown in colour. This reaction is 
referred to as the Maillard or browning reaction and involves an initial 
reaction between sugar and protein called glycation. Once a protein is 
glycated, it undergoes subsequent reactions to form poorly characterised 
structures called advanced glycation endproducts or Maillard products.
1.1: Historical Review of the Maiiiard Reaction
In 1908, an Englishman called Ling first proposed that sugars may react 
with proteins to produce a characteristic yellow brown colour (1 ). However, 
it was Maillard in France who provided the first experimental evidence for 
this reaction in 1912 (2). He did this by heating various amino acids with 
glucose and found that the liquid turned yellow, then rapidly deep brown 
and eventually dark brown polymers called melanoidins were formed. As 
early as 1912, Maillard predicted that this reaction may be of significance in 
vivo. However, his findings were ignored by medical scientists for over 50 
years, and instead became of great interest in food science where the 
reaction is not only important for the production of taste, aroma and colour 
in foods but can also cause loss of their nutritive value. In 1931, Amadori 
described two products ie a stable and unstable isomer formed during the 
initial stages of the Maillard reaction (3). Weygrand in 1940 demonstrated 
that the labile isomer or aldimine is formed first and rearranges to form the 
stable ketoamine named the Amadori product (4).
Interest in the Maillard reaction in vivo began when Rahbar in 1968 showed 
that diabetic patients had elevated amounts of a fast moving haemoglobin 
(Hb) on electrophoresis (5). This Hb designated HbAic comprises about 4%
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of the total Hb in the red blood cell. In the same year, Bookchin and Gallop 
demonstrated that this fraction was "glycosylated" with a 1-amino-2- 
deoxyfructose molecule (or Amadori product) attached to the N-terminal 
valine of the chain (6). Fluckiger and Winterhalter demonstrated that the 
formation of HbAic occurs non-enzymatically because HbAic can be 
synthesised in vitro in the absence of any enzymes (7).
Interest in the role of the Maillard reaction in the secondary complications of 
diabetes and ageing was prompted by the discovery of glycated collagen 
(8), and the observation that complications occur preferentially in tissues 
which do not require insulin for glucose transport.
1.2: Non-Enzymatic Glycosylation (Glycation)
Glycation is also referred to as non-enzymatic glycosylation to distinguish it 
from enzymatic glycosylation which occurs in the endoplasmic reticulum 
during the synthesis of glycoproteins. Such glycoproteins consist of an 
oligosaccharide chain linked via N-acetylglucosamine to an asparagine 
residue (N-glycoside), or an N-acetylgalactosamine to a serine or threonine 
residue from protein (0-glycoside). This enzymatic glycosylation is highly 
regulated and controlled by enzymes called glycosyl transferases. In 
contrast, glycation is a spontaneous reaction between reducing sugars in 
the acyclic form and free amino groups from proteins. Glycation refers to a 
reaction between any reducing sugar and protein whereas terms such as 
glucation, fructation and ribation are used to specify reaction with glucose, 
fructose and ribose respectively.
The oxygen in the carbonyl group has a higher electronegativity than the 
carbon and so the electrons are pulled towards it making the C atom 
electron deficient and the bond is said to be polar. Nucleophilic attack 
occurs on the C atom by reagents which are electron rich such as amino 
groups since they have a lone pair of electrons.
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The glycation reaction starts with a nucleophilic addition reaction between 
the carbonyl group of reducing sugar and free amino group of protein to 
form a labile aldimine or Schiff base (SB).
H C = 0  + NH^-Pr N H -P r  H C = N -P r
H -C —OH —  H -Ç -O H  — ^  H—Ç—OH
HO—C -H  H -Ç -O H  -HjO HO—Ç -H
R H O -C -H  R
I
Glucose ^  Schiff base
This first step is freely reversible and the SB exists as an equilibrium 
between the acyclic and pyranosyl or ring form (9). Inevitably, some of the 
SB rearranges to a more stable ketoamine ie the Amadori product (AP).
H C = N —Pr H C -N H —Pr H jC - N H -P r
H - Ç - O H  = :  ü :-O H  c=0
H O -C -H  H O -C -H  H O -C -H
i  i  i
Schiff base Amadori product
This second step is also reversible but only to a limited extent. For most of 
the time the AP exists in its ring structure ie the 3-furanose and 3-pyranose 
forms. A i^C-NMR study using glucated RNase and polylysine has 
demonstrated that at equilibrium 14% of the glucose is attached as the 
pyranose form of SB and the remainder as the ring form of AP, mostly the 13- 
pyranose form (9). The glycation reaction between glucose and a protein 
(glucation) is outlined in fig 1.1. The relative orientation of substituant 
groups will clearly be different in furanosyl and pyranosyl confomers. This 
could affect noncovalent interactions between glycated proteins and other 
macromolecules, but will have no bearing on covalent reactions of the 
glycation sequence, since these all involve the sugar derived carbonyl. This
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carbonyl is only available in the acyclic form. The conversion of protein to 
SB is freely reversible, although in the continued presence of free sugar the 
equilibrium is displaced heavily in favour of SB. Under these 
circumstances, the equilibrium constant is 3.9 M'^ for glucated albumin and
2.7 M-1 for glucated Hb; the respective dissociation rate constants are 0.39 
and 0.33 M-fh’ T Conversion of SB to AP is essentially irreversible (186).
1.3: Rates of Reaction Between Sugars and Protein
A number of factors have been shown to affect the rate of reaction between 
a protein and a particular sugar in vitro ;
1 : concentration of sugar 
2: duration of exposure to sugar 
3: temperature 
4: pH
5: phosphate concentration
In vivo, the extent of glycation will depend on the degree and duration of 
hyperglycaemia, since the other factors remain constant.
The initial rate of reaction between different sugars and a protein depends 
on three major factors;
1 : the type of carbonyl group ie whether aldose or ketose 
2: the percentage of reducing sugar in the acyclic form 
3: the number of carbon atoms in sugar
The carbonyl groups of aldoses are more polar than those of ketoses and 
so aldoses tend to react approximately 50 times faster than ketoses (10, 
11). Sugars also differ in the proportion of molecules in the acyclic form and 
this is important since only molecules in the acyclic form can react with free
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amino groups. Table 1.1 lists the reaction rate of different sugars with Hb. A 
higher proportion of fructose (0.7%) exists in the acyclic form compared to 
glucose (0.002%) and so would be expected to react some 350 times faster 
than glucose. However, glucose is an aldose and approximately 50 times 
more reactive than fructose. Taking both factors into account, fructose would 
be expected to react approximately 7 times faster than glucose. This agrees 
well with the experimental value obtained in table 1.1. As the sugar 
molecule takes part in glycation, more of the ring form may convert to the 
acyclic form and this rate of interconversion may be important but has not 
been investigated.
The number of C atoms in the sugar are also important and in vitro studies 
have shown that trioses react faster than pentoses which in turn react faster 
than hexoses (11). This is probably because smaller sugar molecules have 
greater accessibility to free amino groups and a higher proportion exist in 
the acyclic form.
Certain groups within the protein structure are more susceptible to glycation 
than others, for eg Bunn et al have demonstrated that the more reactive 
lysines in Hb are located adjacent to acidic amino acids (12). Since th e . 
Amadori rearrangement is an acid catalysed reaction, proton donors 
proximal to these groups could greatly increase glycation. Furthermore 
Iberg and Fluckiger noted that reactive lysine residues in albumin are in 
Lys-Lys, Lys-His, Lys-Lys-Lys and Lys-His-Lys sequences (13).
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1.4: Fate of Glycated Proteins
A glycated protein can enter several different pathways as shown in fig 1.2; 
The glycated protein may;
1 ; be turned over ie catabolised
2: reconvert to the SB which can dissociate to give free protein 
3; be oxidized to give inert compounds
4: undergo further reactions, which may include oxidation to form AGE
1.5 Oxidation of Giycated Proteins
The AP can be oxidized to form;
1 : Carboxymethyllysine (CML) and Erythronic acid (EA) or 
2: Lysino-lactic acid (LL) and Glyceric acid (GA)
The CML and EA are formed by oxidative cleavage between C2 and C3 of 
AP (14) whereas the LL and GA are formed by a split between C3 and C4
(15).
In vitro work using an analogue of glycated lysine called N-formyl-N- 
fructoselysine has demonstrated that CML and LL formation requires 
oxygen and the major product formed is CML. Free radical scavengers 
inhibited production of CML and LL suggesting that a free radical 
mechanism is involved. Fig 1.3 shows formation of CML and LL from 
fructoselysine (FL).
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CHO 
H — OH
HO— C -H
H - C —OH
I
H - C - O H
I
CH2OH
Glucose
N H , — protein
JTv
H
HC=N
I
C
-protein
I
OH
H O -C -H
H - C -O H  ^
I
H - C -O H
I
CH2OH 
Schiff base (SB)
CHjOH
HO \ O H
NH— protein
B-pyranosyl SB
H,C OH
CJH2 ^
? "  . 
proteinOH
B-furanosyl AP
H 2C—N H — protein
C = 0
I
H O -C -H
^  H -C -O H  -k—
• I
H -C -O H
I
CH2OH 
Amadori product (AP)
HO
NH proteinOH
B-pyranosyl AP
Fig 1.1 : Giycation of a protein by glucose (glocation)
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Sugar Type Carbonyl % Acyclic Re! reaction
Glucose Hexose Aldose 0.002 1
Fructose Hexose Ketose 0.700 7.5
Galactose Hexose Aldose 0.020 4.6
Xylose Pentose Aldose 0.020 4.8
RIbose Pentose Aldose 0.040 16.6
Xylulose Pentose Ketose 8.000 25
Table 1.1: Relative rates of reaction of various sugars with haemoglobin 
(adapted from ref (169)).
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Schiff base fluorescent
crosslinks
catabolism Amadori product ^  non-fluorescent 
crosslinks
CML + LL fluorophores
Fig 1.2: The various pathways that a glycated protein may enter
Ç H ,— N H —lysine
C = 0
I
H O - C -H
I
H - C -O H
I
H - C -O H
I
CHgOH
FL
N H —lysine 
H - C - H  + 
COOH 
CML
N H —lysine
H - C - H
I H
H -C -O H
I
CH2OH
LL
COOH
I
H - C - O H
I
H - C -O H
CH2OH
EÀ
COOH
I
H - C -O H
I
CH2OH
GA
Fig 1.3: Oxidative degradation of FL to give CML and LL
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1.6: Advanced Giycation Endproducts
Once a protein is glycated, it can go on to form advanced giycation 
endproducts (AGE) by reactions between the AP and other AP's or free 
amino groups from the same or different protein, AGE form slowly and since 
proteins are continually turned over, only long lived proteins will 
accumulate them to any great extent in vivo. The limited information 
available on the structure of AGE suggests that they may be;
1 : fluorescent crosslinks 
2: non-fluorescent crosslinks 
3: fluorophores
The latter are fluorescent groups attached to proteins which may be 
capable of forming crosslinks. Formation of AGE is believed to involve 
reactive dicarbonyl intermediates called glucosones. Kato in 1961 first 
isolated glucosones as intermediates in the Maillard reaction in model 
systems. Glucosones are formed by degradation of the AP regenerating the 
free amino group and there are three different typés (reviewed in (16)). Of 
the three glucosones, 3-deoxyglucosone (3-DG) shown in fig 1.4 has 
received the most attention and is the most important with respect to pyrrole 
formation (17) and protein crosslinking (18). A possible pathway for 
formation of 3-DG may be similar to that proposed by Anet in 1960 (159). 
The AP or fructoselysine may react with free sugar to form a difructoselysine 
compound which may dissociate to give fructoselysine and 3-DG (see fig 
1.4). However the precise mechanism for 3-DG formation is not yet knôwn 
and it is now believed that a free amino group is generated after 3-DG 
production from an AP which is not the case in the pathway shown in fig 1.4
(16).
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Chemical characterisation of AGE has proved difficult because of their 
complexity, low yields, their destruction during acid hydrolysis and 
generation of artefacts during their isolation. However, despite these 
difficulties three different types of AGE have been reported in the literature.
1.6.1: Furoyl-Furanyl-lmidazole (FFI)
There is only controversial evidence for the existence of this AGE believed 
to be formed from two AP's and characterised by Pongor et al (19) in 1984. 
FFI was extracted into chloroform as a fluorescent pigment from glucated 
bovine serum albumin (BSA) and poly-L-lysine after they had been acid 
hydrolysed and alkalised in ammonia. This pigment was purified by silica 
gel chromatography and its structure determined by NMR, mass 
spectrometry and chemical analysis. However, in 1988 Njoroge et al 
demonstrated that FFI is an artefact formed during the extraction process 
(20). Furosine is produced during acid hydrolysis of glycated proteins and 
in alkaline solutions is converted to furoyl glyoxal which can react with 
ammonia to form FFI. Using labelled ammonia, this group showed that 
the nitrogen atoms in FFI were derived from ammonia and not amino 
groups. The structure of FFI is given in fig 1.5.
1.6.2: Pyrraline
Four pyrrole compounds have been isolated from model systems by 
reacting neopentylamine with glucose under physiological conditions (21). 
All of these pyrroles have been detected previously in reaction mixtures at 
higher temperatures (22, 23) and all possess a carbonyl group which could 
be capable of reacting further to form protein crosslinks. A polyclonal 
antibody has been raised to one of these pyrroles named pyrraline (fig 1.6) 
and used to develop an ELISA (24). This immunological approach was 
necessary since acid hydrolysis destroys the compound. Using the ELISA, 
elevated pyrraline levels have been detected in albumin from diabetic
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subjects ie 40 pmol/mg compared to 28 pmol/mg from controls. Although 
the mechanism for pyrraline formation is not yet known, it is believed to be 
formed by a reaction between free amino groups and 3-DG.
1.6.3: Pentosidine
In 1989, a fluorescent crosslink was isolated from the dura mater of ageing 
individuals and subsequently characterised by proton NMR and fast atom 
bombardment (25). This AGE named pentosidine consists of an arginine 
residue linked to a lysine residue via a pentose group as shown in fig 1.7. 
Pentosidine has been synthesised in vitro by incubating pentoses with 
equimolar amounts of lysine and arginine or with collagen. More recent 
studies have shown that pentosidine can be formed by reacting proteins 
with glucose, fructose and ascorbate in the presence of oxygen (26, 27). 
Furthermore, pentosidine has been shown to account for less than 1% of 
non-disulphide crosslinks in glucated lysozyme or RNase suggesting that it 
is not a major sugar-derived crosslink (26). Accumulation of pentosidine 
occurs in tissue collagens with age and at an accelerated rate in diabetes 
(28). Trace amounts of pentosidine have been found in human lens protein 
where its concentration increases with age (26). Another fluorescent 
crosslink named Maillard Fluorescent Product-1 (MFP-1) can form when 
proteins are incubated with glucose and accumulates in tissue proteins with 
age and diabetes in vivo (29). MFP-1 and pentosidine have similar 
absorbance and fluorescence spectra and recent findings suggest that they 
are the same compound (26).
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1.7: Autoxidative Giycation and Free Radicals
Monosaccharides are known to exist in equilibrium with their enediol which 
can undergo autoxidation in the presence of transition metals to form an 
enediol radical anion (30). This enediol radical anion has an unpaired 
electron and reduces molecular oxygen to generate the superoxide anion 
radical (02 "). Two superoxide radicals can react to form hydrogen peroxide 
(H2O2) ie:
O 2  +  O 2  -----------------— ---------------------►  H 2 O 2  +  O 2
Nanomolar quantities of hydrogen peroxide have been detected during 
experimental giycation (31). A Fenton reaction may occur between this 
H2O2 and transition metals such as Fe2+ or Cu+ to generate the highly 
reactive hydroxyl radical OH ie;
Cu+ + H 2O2 --------------------------- ► OH + Cu^+ + OH
Hydroxyl radicals generated from other sources for eg by gamma radiolysis 
of water are known to induce protein fragmentation (32), and this has led to 
the suggestion that fragmentation of proteins incubated in glucose is due to 
hydroxyl radicals generated by autoxidation of the sugar (33). Furthermore, 
hydroxyl radicals can also induce protein crosslinking and fluorescence 
particularily in the absence of oxygen. Some crosslinking does occur in the 
presence of oxygen but fragmentation is then much more pronounced (34). 
The metal chelators DETAPAC and EOTA inhibit protein fragmentation 
probably by sequestering the trace amounts of transition metal necessary 
for hydroxyl radical production (33). The superoxide radical is not as 
reactive as the hydroxyl radical and does not cause fragmentation (35). 
When forming the superoxide radical, the enediol radical anion itself is 
oxidized to form a dicarbonyl compound called a ketoaldehyde (36). The
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process of autoxidative giycation is outlined in fig 1.8. Wolff et al have 
proposed that ketoaldehydes react with free amino groups to form 
structures called ketimines which are distinct from the ketoamines or AP 
and may participate in crosslinking and fluorescence (AGE) of proteins (36). 
This has led to the suggestion that antioxidants may be of therapeutic 
potential by inhibiting autoxidative giycation in vivo (33). However, this 
hypothesis has received considerable criticism since at present there is no 
evidence for ketimines in vivo or in vitro (37). Borohydride reduction of 
keti mines would form deoxyaminohexitols identical to those produced by 
ketoamines and therefore it would not be possible to distinguish between 
the products formed by giycation and those formed by autoxidative 
giycation. Whether ketoaldehydes formed by autoxidative giycation 
contribute significantly towards total monosaccharide attached to protein in 
vivo remains to be proved. It is noteworthy that levels of transition metals 
such as copper increase during diabetes (38) whereas plasma levels of 
antioxidants such as uric acid, vitamin C, vitamin E and glutathione 
decrease in diabetes (reviewed in (39)).
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1.8: Measurement of Giycation
Assays for glycated proteins can be performed on intact proteins or protein 
hydrolysates, and those which detect the AP and not SB are preferred since 
the labile SB can dissociate to different extents giving rise to inconsistent 
results. Free sugars interfere in some assays and have to be be removed by 
dialysis.
1.8.1: Thiobarbituric Acid (TBA) Assay
Mild acid hydrolysis of the AP form of glycated proteins causes release of 
hydroxymethylfurfural (HMF) (40). After removal of protein, loss of H2O 
occurs and the HMF produced (fig 1.9) can be reacted with thiobarbituric 
acid (TBA) to form a chromophore which absorbs at 443nm. Alternatively, 
the HMF can be detected by its A28O aRer separation by HPLC (41). The 
nett production of HMF depends on its release and destruction during 
hydrolysis and so the assay is non-stoichiometric. However, it has 
advantages in that all AP's whether they are attached to alpha or epsilon 
amino groups are detected and the SB does not interfere. Collagen 
crosslinks do not interfere in this method but glycoproteins with acid labile 
glycosidic bonds and free sugars have been shown to interfere (42).
1.8.2: Periodate OxIdatlon/DDL Assay
Periodate oxidation of a glycated protein causes release of the sugar group 
from protein and production of performic acid and formaldehyde. The bonds
cleaved by periodate oxidation (based on Malaprades rule) are;
Ç -O H  C=NR C -N H R  C -O H  C -N H R
- F -  - I - -  4 - -  -i__
C -O H  C -O H  C -O H  C = 0  C = 0
Formaldehyde is released only from 0-1 and 0-6 atoms of straight chain 
hexoses which are adjacent to a O-OH or 0= 0  group (43). AP in the 
pyranosyl or furanosyl form will therefore release one mole of formaldehyde
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per mole of AP whereas AP In dhe acyclic form will release two moles of 
formaldehyde per mole AP (fig 1.10). SB in the acyclic form will also release 
one mole of formaldehyde but can be removed by dialysis and since 
virtually all the AP exists in the ring form, approximately one mole of 
formaldehyde is released per mole of AP. The released formaldehyde is 
detected by conversion to diacetyldihydrolutidine (DDL) as in the Hantzsch 
reaction (44). Free sugars interfere in this method and have to be removed 
by dialysis and so do glycoproteins with chain terminal reducing sugars or 
sialic acid residues. However, this method has the advantage that it is 
stoichiometric and will detect giycation at both alpha and epsilon amino 
groups.
1.8.3: Phenylhydrazine Assay
Amadori products possess carbonyl groups and methods which measure 
these could be used to quantify giycation. Earlier attempts to measure 
giycation of Hb using phenylhydrazine were unsuccessful and this was 
attributed to the small percentage of glucose-AP existing in the acyclic form 
(156). More recently, the method has been used to assay for giycation of 
albumin (157) and reaction between glyceraldehyde and Hb (158). 
Phenylhydrazine (via its amino group) reacts with carbonyl from AP to form 
a coloured hydrazone whose absorbance is measured at 405nm (fig 1.11).
1.8.4: Fructosamine Assay
This assay is used in routine clinical laboratories to measure the AP 
(fructosamine) in serum protein. In alkaline conditions, ketones (like the AP) 
can be reduced to give an eneaminol, which undergoes dehydration to 
produce a strong reducing agent or enediol. This enediol can reduce 
nitroblue tétrazolium (NBT) by an unknown mechanism to produce a blue 
black colour which can be quantified (45). Ketoses enolize faster than 
aldoses and so the SB and free glucose will not interfere in this method. A
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major problem with the fructosamine assay is that it is difficult to standardize 
because the colour varies with protein, dye concentration, pH, temperature, 
and time (46, 47).
1.8.5: Borohydride Reduction
Reduction by borohydride occurs at the C=N bond in SB and C=0 in 
glucose-derived AP stabilizing the sugar-protein link to form 
deoxyaminosorbitol (ie glucitol-lysine) as the major product whereas a 
small amount of deoxyaminomannitol is also formed from the AP. To 
increase sensitivity, tritiated borohydride is used (48) and following 
reduction the protein is hydrolysed to its constituent amino acids. The 
glucitol-lysine can be separated by amino acid analysis since it elutes 
between the aromatic and basic amino acids. This method has the 
advantage of being very sensitive, but is not very specific and free sugars, 
SB, collagen crosslinks and glycoproteins will interfere.
1.8.6: Phenylboronate Affinity Chromatography
An affinity chromatography method for measuring glycated proteins was 
developed in 1980 using boronic acid linked to agarose by an m- 
aminophenyl spacer (49). At pH >7, the boronic acid ionises so that the OH 
groups can be replaced by cis did groups from the AP. The labile SB 
dissociates during chromatography, and glycoproteins do not bind as 
strongly as glycated proteins. Bound protein is eluted by washing with a 
buffer containing a high concentration of sorbitol or HOI. The amount of 
glycated albumin bound to the column varies from 6.3% (50) to 20% (51) 
probably due to differences in conditions such as temperature, pH, sample 
size, flow rate and buffer composition. This method has been adapted for 
routine use in the measurement of glycated Hb by Gould et al (52).
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1.8.7: Furosine Assay
Acid hydrolysis of glycated proteins will result in the AP being converted to;
1 : furosine (30%)
2: lysine (50%)
2: pyridosine (20%)
Furosine can be separated by HPLC and its A28O measured (42). This 
method is very sensitive ie only requires 15-25ug of protein, is very specific, 
and free sugars, SB, glycoproteins and collagen crosslinks do not interfere. 
However, yields of furosine are poor ie only 30%, and only lysine giycation 
is detected.
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1.9: Measurement of AGE
At present there are no simple specific assays for measuring AGE and 
those for measuring pyrraline (24) and pentosidine (25) are restricted to a 
few laboratories. The simplest methods for AGE detection rely on their 
characteristic fluorescence and crosSlinking properties.
1.9.1 : Fluorescent-AGE
Many AGE have characteristic absorbance and fluorescence spectra which 
can be used for their detection. This is a very crude method since a large 
number of other compounds can also fluoresce. For the results to be 
meaningful, values have to be normalised with respect to protein 
concentration.
1.9.2: Crosslinked-AGE
Polymerisation of molecules as a result of AGE formation has been 
demonstrated for many proteins including lens crystalIIn (53), albumin (54), 
RNase (55) and collagen (56), and this property can be used to detect AGE. 
First the protein is treated with mercaptoethanol or dithiothreitol to eliminate 
crosslinks due to disulphide bonds, subjected to SDS-PAGE and then 
scanned by laser densitometry to calculate the percentage oligomer (57).
1.10: Role of Giycation and AGE In Diabetes and Ageing
One of the major problems that individuals with long standing diabetes face 
is the increased susceptibility to secondary complications which include;
1 : retinopathy 
2: cataract 
3: atherosclerosis 
4: nephropathy 
5: neuropathy
Page 27
6: limited joint mobility
As a consequence of these complications, the life expectancy of diabetics is 
only 2/3 of that of the general population (58). Hyperglycaemia is a major 
causative factor in the development of these complications and diabetics 
with poor blood glucose control are particularly at risk (59). Furthermore, the 
incidence of many of these complications increases with age even in non­
diabetics.
Giycation of several proteins has been shown to increase in diabetes (60, 
61), and virtually any protein can be glycated in vitro. Although earlier work 
has suggested that protein giycation increases with age (62, 63), more 
recent studies have not confirmed these findings (64, 65). Giycation would 
not be expected to increase with age since it should reach steady state 
levels in equilibrium with glucose concentrations, AGE formation and 
protein turnover.
Theoretically, giycation and AGE formation could alter protein conformation 
and may impair function in several ways;
1 : altered enzymatic activity 
2: decreased ligand affinity 
3; modified protein half life 
4: blocking of proteolytic sites 
5: altered immunogenicity
Giycation of RNase in vitro reduces its activity by 50% probably by blocking 
lysine-41 essential for its function (55). In contrast, giycation increases the 
activity of aldose reductase in vitro (66), but has no effect on the proteases 
trypsin and chymotrypsin (67). In vitro glycated insulin has reduced 
biological activity which can be demonstrated on fat cells as reduced
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glucose oxidation, increased fatty acid synthesis and reduced antilipolytic 
properties (68). Because of its very short half life, giycation of insulin in vivo 
would not be expected, and so the above findings are only of theoretical 
interest.
About 6-15% of albumin, the major serum protein is glycated in 
normoglycaemic individuals (69), but a two fold rise occurs in diabetics (70). 
The major site of giycation in albumin is lysine-525 in vivo (71) and 
giycation of the same site occurs preferentially in vitro causing a 
conformational change (72). As a result, the binding of bilirubin and fatty 
acids decreases by 2 and 20 fold respectively. However, binding of 
palmitate is unaffected by giycation of albumin to extents found in vivo (73).
Giycation of LDL is increased in diabetics where upto 5% of lysine residues 
in apoprotein 8 are modified compared to only 3% in non-diabetics (74), 
and this extent of giycation has been reported to be sufficient to impair its 
binding and uptake via the LDL receptor in fibroblasts and endothelial cells 
in vitro (75). Since 75% of LDL clearance is mediated by the LDL receptor, 
this may account for the higher plasma levels of LDL in diabetics (76). 
Schleicher et al however, have found that giycation of LDL to extents seen 
in diabetes does not affect its catabolism by fibroblasts (77). Formation of 
AGE on LDL increases their binding and uptake by macrophages which 
possess a specific receptor that recognises AGE but not the AP in vitro (78). 
This pathway is independent of the classical scavenger pathway and the 
receptor has recently been purified and shown to be a protein of 90KD (79).
Giycation of lens protein in vitro and in vivo was first reported by Stevens et 
al in 1978 who suggested that conformational changes induced by 
giycation could expose SH groups to oxidation and disulphide formation 
(80). Furthermore, lens protein incubated with glucose or glucose-6- 
phosphate slowly becomes brown and produces fluorescence spectra
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similar to that by lens protein from cataract (81). Increased AGE in addition 
to disulphide crosslinks may therefore be involved in cataract formation.
Collagen, the major structural protein has increased giycation in diabetes 
for virtually every tissue analysed including basement membranes from 
both kidneys and lens capsule (82), aorta (83), tail tendon (84) and skin 
(85). Earlier work has reported increased giycation of collagen with age 
from skin (86), glomerular basement membrane (87), bone, tendon and 
cartilage (88). However, recent studies using more specific methods have 
found no increase in giycation with age (89) or only slight increases that 
can be correlated with age associated increases in glycaemia (90). The 
above discrepancies are probably due to differences in the methods used 
to assay for giycation, since most of the earlier work is based on the TBA 
assay which is susceptible to interference by glycoproteins whereas the 
more recent methods ie furosine method have overcome these problems. 
Increased crosslinking, rigidity, browning, fluorescence and reduced 
susceptibility to proteolysis occurs with collagen in vitro (91). Such changes 
have been used as markers for AGE and have been shown to increase with 
age (92) and in diabetes (93). Whether the above changes are due solely to 
glycation-induced AGE is not yet certain since other processes such as free 
radicals may also have the same effect (94). AGE crosslinks in collagen 
have been implicated in the limited joint mobility (LJM) syndrome seen in 
40% of insulin-dependent diabetics. This suggestion has been supported 
by the finding that collagen from patients with LJM has higher fluorescence 
and crosslinking compared to those without (95). Brownlee et al using 
immobilised collagen on agarose have shown that collagen-AGE can 
covalently trap LDL. At a constant LDL concentration, covalent trapping 
increased linearly with the extent of collagen-AGE (96). Excessive trapping 
of plasma proteins by hyperglycaemia-induced collagen-AGE in the arteries
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and glomerular basement membrane may contribute towards the 
accelerated development of atheroma and nephropathy respectively in 
diabetes.
AGE formed on glycated myelins either in vitro or from diabetics increases 
their susceptibility to phagocytosis by macrophages stimulating them to 
secrete proteases (97). Whether this contributes towards the demyelination 
of nerve fibres seen in diabetic neuropathy has not yet been proven.
1.11: Fructation and the Sorbitol Pathway
Since glucose is the major metabolic sugar, glucation has received the 
most attention. However, other reducing sugars present in vivo can also 
participate in giycation and do so much faster than glucose in vitro. In vivo, 
these sugars are present in minute concentrations and have therefore been 
ignored except for galactose which has been investigated with respect to 
galactosaemia (98). In vitro studies using radiolabelled sugars have shown 
that fructose reacts and forms the labile SB some 8 times faster than 
glucose with Hb (11). In addition, fructose induces AGE formation upto 10 
times faster than glucose in vitro with albumin (99), RNase (57), lens protein 
(100) and collagen (101).
Rich sources of fructose in the diet include fruits, honey and sucrose. 
Fructose is considered safe for diabetics and is a permitted sweetener in 
diabetic foods. A number of reasons have been given for this;
1 : Since fructose is much sweeter than glucose, one is likely to consume
less.
2: Fructose is rapidly metabolised in the liver and its levels in the plasma
are well below 1 mM.
3; Fructose unlike glucose does not require insulin for its metabolism and 
can enter glycolysis.
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In the liver, fructose can be converted to glycogen which will ultimately 
release glucose and for this reason, some diabetologists have argued 
against using fructose in diabetic foods. The relationship between fructose 
and other metabolic pathways is shown in fig 1.12. The possibility that 
dietary fructose may contribute towards in vivo glycation has been virtually 
ignored presumably because of its low plasma levels (102). However, there 
are interesting studies regarding dietary fructose in diabetes;
1 : A study in Japan has shown that diabetics have higher serum fructose
levels compared to non-diabetics after ingestion of a fructose-rich diet 
(103).
2; A case study of a diabetic with high glycated Mb values but normal 
blood glucose levels highlights the dangers of eating too much 
fructose (104). This individual was on a high fructose diet and tests for 
reducing sugars in urine revealed the presence of fructose. When the 
high fructose diet was stopped, glycated Mb values returned to normal 
within two months yet daily blood glucose levels remained the same.
3: Patients with hereditary fructose intolerance have elevated serum
fructose levels and have higher than normal levels of glycated Mb 
(105).
4: Long term administration of fructose in the diet has led to lesions
similar to diabetic microangiopathy in rats (106).
Apart from dietary fructose, there are regions in the body where the fructose 
accumulates and in these regions the sorbitol pathway operates. In 
diabetes the sorbitol pathway is highly active and glucose is converted to 
sorbitol and fructose under the influence of the enzyme aldose reductase 
(107). The sorbitol pathway has been detected in the lens (108), nerves 
(109), arteries (110) and retina (111) ie regions associated with diabetic
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complications. Furthermore, the sorbitol pathway is also of interest in 
diabetes because it is believed that sorbitol accumulation within cells can 
produce a high intracellular osmotic pressure which may cause cell 
damage and thus contribute towards the pathogenesis of diabetic 
complications. However, very little attention has been paid to the levels of 
fructose which can increase by 23 fold reaching and even exceeding the 
levels of glucose (112). One study has reported concentrations of fructose 
upto 12mM in the lens (108), and clearly significant fructation may occur 
here. Indirect evidence for in vivo fructation by the sorbitol pathway has 
been presented by Suarez et al who demonstrated that administration of 
sorbinil, an aldose reductase inhibitor decreased collagen-linked 
fluorescence in diabetic rats (113). In contrast, Cohen et al found no 
decrease in collagen-linked fluorescence after administration of sorbinil 
(114). In both these studies, fluorescence of an extracellular protein was 
measured, whereas the sorbitol pathway is an intracellular event. Sorbinil 
does not affect levels of glycaemia (115), but one report has claimed it to be 
a free radical scavenger (80) and therefore its effect may be by an 
alternative mechanism. Odetti et al have also reported decreased collagen- 
linked fluorescence in diabetic rats receiving rutin which is also an aldose 
reductase inhibitor (116). It is noteworthy that glycation of aldose reductase 
actually increases its activity in vitro (66). Finally, direct evidence for in vivo 
fructation has been presented by McPherson et al who have reported that 
20% of the AP in lens protein is derived from fructose (57).
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Fig 1.12: Metabolism of fructose (key; aldose reductase (AR), fructokinase 
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1.12: Inhibitors of Glycation and AGE Formation
There is a possibility that the body may possess mechanisms to protect 
against glycation and AGE formation. An enzyme alpha-ketoglutaraldehyde 
dehydrogenase found in the liver can inactivate deoxyglucosones in vitro 
(117), and macrophages can recognise and endocytose molecules 
modified by sugars (78). Preliminary studies by Vlassara et al have shown 
that the ability of mouse peritoneal macrophages to remove AG E-proteins 
decreases with age (118). Such an effect in humans may explain the higher 
incidence of diseases such as atherosclerosis with increasing age. A 
variety of amines in plasma such as taurine, free amino acids, creatine and 
guanidine are capable of blocking carbonyl groups on sugars, AP's and 3- 
DG and may reduce sugar-induced damage in vivo. However, the efficiency 
of these natural defence mechanisms in vivo is not yet known.
At present there is considerable interest in pharmacological compounds 
which could reduce or prevent glycation and post-Amadori reactions in vivo 
because of their therapeutic potential.
1.12.1: Aminoguanidine
This nucleophilic hydrazine with three amino groups has received the most 
attention. Brownlee et al in 1986 were the first to demonstrate that 
aminoguanidine could reduce glucose-derived fluorescence and 
crosslinking of collagen and albumin in vitro (119). In the same study, 
aminoguanidine administered to diabetic rats for 16 weeks reduced 
crosslinking of aortic collagen and basement membrane thickening in the 
kidneys. A more recent study by Odetti et al has shown that aminoguanidine 
not only reduces collagen-linked fluorescence in diabetic rats but has no 
effect on glycaemia or glycated Hb levels (116). Brownlee et al proposed 
that aminoguanidine blocked free carbonyl groups on AP therefore 
inhibiting AGE formation but not glycation (120). The protein-
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aminoguanidine complex which would be expected to form as a result has 
never been identified and more recent studies suggest that there may be 
more than one site of action. Indeed, aminoguanidine can reduce glycation 
in vitro by reacting with the free sugar (121), and AGE formation by blocking 
3-DG (122). The possibility that aminoguanidine may reduce oxidative 
processes since it is a known inhibitor of diamine oxidase have not yet 
been excluded (123). At present nothing is known about the metabolism of 
aminoguanidine or its complexes.
In vivo aminoguanidine could react with other naturally occurring carbonyl 
compound and may impair their function for eg reaction between 
aminoguanidine and pyridoxal phosphate may lead to vitamin Bg 
deficiency (124).
1.12.2: Acetylsalicylic acid
A study by Cotlier in 1981 suggested that frequent use of aspirin may 
protect against diabetic cataract. This study found that the prevalence of 
cataract was significantly lower in diabetics with rheumatoid arthritis 
receiving high doses of aspirin compared to a matched population on no 
aspirin (125). Acétylation of amino groups by aspirin (acetylsalicylic acid) 
has been shown to reduce glycation of albumin, haemoglobin (126) and 
lens protein (127) in a dose dependant manner in vitro, and this led to the 
suggestion that aspirin may protect against diabetic cataract by preventing 
glycation (128). However, other analgesics such as paracetamol and 
ibuprofen also have a protective effect against cataract yet cannot acetylate 
proteins (129). Therefore, the protective effect of aspirin may be due to other 
mechanisms since aspirin has been reported to reduce glycaemia (130), 
inhibit sorbitol pathway activity (125) and stimulate the release of insulin 
(131). A recent study has shown that administration of aspirin in diabetic 
rats reduced glycation of lens protein without affecting glycaemia (132).
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1.12.3: Antioxidants and Free Radicai Scavengers
Vitamin E has been shown to decrease glycation of albumin in a dose 
dependant manner in vitro (133), and more recently therapeutic doses of 
the vitamin (800mg/day) have been shown to reduce HbAic levels in 
diabetics (134). The mechanism of action of vitamin E is not yet known but 
could reduce autoxidation of sugars preventing their incorporation into 
proteins. Another antioxidant, vitamin C has also been shown to inhibit 
glycation of serum proteins both in vitro and in vivo (135). Free radical 
scavengers may prevent fragmentation, fluorescence and crosslinking of 
proteins by sugar-derived free radicals. The free radical scavenger sorbitol 
has been reported to inhibit glucose-derived fragmentation of albumin in 
vitro (33).
1.13: Brief Review of Proteins Used in this Study
The model proteins used in this study include serum albumin (human and 
bovine), lysozyme and ribonuclease. These proteins were chosen since 
they are soluble, relatively inexpensive and have already been studied with 
respect to glycation.
1.13.1: Albumin
Albumin is the major plasma protein with a half life of 19 days and a 
concentration of approximately 40 mg/m I in vivo. The essential function of 
albumin is to maintain osmotic pressure of blood and to transport a variety 
of substances such as fatty acids and bilirubin. Albumins have a high 
content of lysine, arginine, cysteine and aspartic acid and a low content of 
tryptophan and methionine. Due to the high cysteine content albumin has 
17 disulphide bonds which give the protein its stability. Both human serum 
albumin (HSA) and bovine serum albumin (BSA) contain 59 lysine residues 
per molecule. Albumin can bind a number of positively charged ligands
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including Ca2+, Cu2+, Ni^+and Zn2+ as well as drugs such as acetylsalicylic 
acid, warfarin and ampicillin (reviewed in (136)).
1.13.2: Lysozyme
This enzyme can lyse bacterial walls and egg white is a rich source of the 
protein. Lysozyme is a single polypeptide consisting of 129 amino acids 
and has 4 disulphide bonds which give the molecule its stability. Lysozyme 
contains 6 lysine and 11 arginine residues and has a molecular weight of 
14,300. At present there is no information on in vivo glycation of lysozyme. 
However the protein has been glycated in vitro and readily polymerises 
(137).
1.13.3: Ribonuclease
This enzyme can cleave ribonucleic acids (RNA) and has a molecular 
weight of 13,700 with 4 disulphide bonds. The molecule is a single 
polypeptide of 124 amino acids with 10 lysine and 4 arginine residues. At 
present there is no evidence for in vivo glycation of RNase, however, in vitro 
studies have shown that Lys-1 and Lys-41 are more reactive than the other 
lysine residues (9). Glycation at Lys-41 in RNase causes a loss in activity of 
the enzyme (55).
1.14: Alms and Objectives
The specific aims for each experimental chapter are listed after the 
introduction to that chapter. Here the overall aims of the thesis will be 
summarised and listed below;
1: To improve sensitivity, speed and yield of DDL in the periodate
method so that it can be used as a rapid assay to measure absolute 
values of glycation in small amounts of intact protein.
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2: To improve sensitivity, speed and yield of HMF in the TBA method so
that it can be used as a rapid assay for small amounts of glycated 
collagen.
3: To evaluate the potential role of fructose during in vivo glycation and
AGE formation by in vitro experiments using model proteins.
4: To investigate whether other glycation assays apart from the periodate
method will underestimate the true AP levels in fructated BSA and the 
possible reasons for this.
5: To elucidate mechanisms of AP and AGE formation using different
proteins, phosphate concentration, pH, sugars and inhibitors.
6: To evaluate the possible role of autoxidative glycation and free radical
mediated protein fragmentation in vivo by studying the reaction in vitro.
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CHAPTER 2
Materials and Methods
2.1: In Vitro Glycation Procedure
Proteins of known concentration were incubated in different sugars (M/I) in 
either sodium or potassium phosphate buffer (M/I), pH 7.4 at 370C in a 
Memmert universal oven (Model No UM 100/1) for a stated period of time. 
Where necessary, 0.05M Tris or HEPES, pH 7.4 was used instead of 
phosphate buffer. To prevent bacterial growth, solutions contained 3mM 
sodium azide or were passed through polydisc (0.45u) (Whatman, 
Maidstone, Kent, UK) under sterile conditions. Incubations with azide have 
the disadvantage in that azide may interfere in reactions of glycation and 
AGE formation for eg azide could act as a free radical scavenger. 
Incubations performed under sterile conditions overcome these problems 
but are unsuitable for prolonged incubations since bacterial growth may 
occur. Furthermore facilities must be available to perform sterile techniques. 
The pH of incubations was checked periodically using a Schott Gerate pH 
meter (Model No CG 727) and adjusted to the desired value if necessary. 
All manipulations with proteins were performed on ice. At the appropriate 
time, glycation was terminated by freezing the sample to -40°C.
2.2: Removal of Unbound Sugar
Dialysis tubing with a mwco of 12-14,000 (Medicell International Ltd, 
London, U.K) was used for albumin and that for lysozyme and RNase, had a 
mwco of 6-8,000 (Spectrum Medical Industries, Los Angeles, CA, USA).
Preparation of Dialysis Tubing: Tubing was soaked for one hour in 1% 
acetic acid followed by rinsing in distilled water for 15 mins. The tubing was 
then soaked for 15 mins in a solution of 1% sodium carbonate containing 
lOmM EDTA. The tubing was heated to 75°C twice in this solution before
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being rinsed in distilled water and heated to 75°C again. After a quick rinse, 
the tubing was stored at 4°C in distilled water to which a few drops of 
chloroform had been added.
Dialysis Procedure: Samples were dialysed by stirring in 21 of distilled 
water or buffer at 4°C in the dark over a period of 3-4 days with 8 changes. 
A minimum of 4 hours was allowed between each change. Adequate 
dialysis was important for removal of free sugars which can interfere in 
protein as well as glycation assays. Extensive dialysis has also been 
reported to remove the labile SB which can interfere in the periodate assay 
(57). Dialysed proteins were stored frozen at -40°C, and this has been 
reported to cause no increase in glycation (138).
2.3: Collagen Digestion
Dialysed glycated collagen was centrifuged at 9000g for 10 mins and the 
precipitate resuspended in 0.05M sodium phosphate buffer, pH 7.4 
containing 200IU collagenase and incubated at 37<>C for 48 hours. 
Chloroform and toluene (5ul each) were added to prevent bacterial growth. 
After centrifugation at 9000g for 10 mins, the supernatant was collected and 
stored frozen.
2.4: Protein Assays
Protein concentrations were determined according to three different 
methods;
2.4.1: Lowry Protein Assay
In the method of Lowry et al (139), reagent A (2% NaaCOa in 0.1 M NaOH) 
and reagent B (0.5% CUSO4 .5 H2O in 1% Na-K tartarate) was mixed in the 
ratio of 50:1 respectively, and 1ml of this was added to 0.1ml of sample or 
standard followed by incubation at room temp for 30 mins. After incubation.
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0 .1ml of Folin Ciocalteau's phenol reagent was added whilst vortexing 
tubes, which were then left at room temp for 15 mins before measuring the 
absorbance at 750nm using a Gilford 260 Spectrophotometer. A calibration 
graph ranging from 0-50ug BSA was also prepared (fig 2.1). All samples 
were assayed in duplicate and the results expressed as nmols protein/ml or 
mg/ml.
2.4.2: Pierce BCA Mioroassay
A microversion of the bicinochoninic acid (BCA) method of Smith et al (140) 
was used. To 0.02ml of sample or standard in microplate was added 0.2ml 
of reagent A (NaaCOa , NaHCOa , BCA detection reagent and sodium- 
tartarate in 0.2 M NaOH) and reagent B (4% CUSO4 ) in the ratio of 50:1. 
The microplate was covered and stirred in a Wellmixx 1 microplate stirrer 
(Model No WM 503) for 1 min before incubation at 37°C for 30 mins. 
Absorbance at 570nm was measured using a Biotek microplate reader 
(Model No EL311) with a 570nm filter. A calibration graph using known 
amounts (0-20ug) of the protein being assayed was also prepared. The 
calibration graph for 0-20ug of BSA is shown in fig 2.2. All assays were 
performed in duplicate and the results expressed as nmols protein/ml or 
mg/ml.
2.5: Reductive Méthylation of Glycated BSA
Reductive méthylation of BSA was performed according to the procedure of 
Jentoft and Dearborn (142). Glycated BSA (~5mg/ml) was stirred slowly in 
0.05M sodium phosphate buffer, pH 7.4 with 2mM formaldehyde and 20mM 
sodium cyanoborohydride for 6 hours at 4°C in the dark and then dialysed 
overnight against 21 of the buffer. It was necessary to repeat this procedure 
(5-6 times) until adequate blocking of amino groups was achieved as 
measured by the TNBS method. Finally the methylated BSA was dialysed
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exhaustively to ensure complete removal of formaldehyde and sodium 
cyanoborohydride. Removal of formaldehyde was particularly important 
since it can interfere in the periodate assay used to quantify glycation.
2.6: Proteinase K Digestion
Prior to any fluorescence readings, the reductively methylated (RM) BSA 
was digested by 12.5 ug/ml of proteinase K for 18 hours in 0.05M sodium 
phosphate buffer, pH 7.4 at 37^0 and boiled for 1 min to destroy enzyme 
and then briefly centrifuged. Activity of the enzyme was measured by the 
rise in amino groups as detected by the TNBS method.
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2.7: Trinitrobenzene Suiphonic Acid (TNBS) Method
Amino groups were determined according to the method of Spadaro et al 
using TNBS (143). To 0.4ml of sample or standard was added 0.2ml of 
5mM TNBS followed by 0.4ml of 1M potassium borate buffer, pH 9.2. After 
incubation at room temp for 40 mins, 0.2ml of 18mM Na2SOs in 2M 
NaH2P0 4  was added and the tubes vortexed. Absorbance was measured 
on a Gilford 260 Spectrophotometer. A calibration graph was prepared 
using known amounts (0-62.5nmols) of N-acetyl-L-lysine-N-methylamide 
(NALMA) and is shown in fig 2.3. All assays were performed in duplicate 
and the results expressed as nmols NH2/ml of protein solution.
2.8: Measurement of Giycation
Assays used to measure glycation in this project provided a measure of the 
AP alone since the SB was removed during dialysis. These assays include;
2.8.1: Periodate Oxidation Assay (Gaiiop procedure)
The procedure of Gallop et al was used (43). The sample or standard was 
made upto a volume of 700ul in distilled water and 20ul of 1M MCI followed 
by lOOul of 0.1 M Nal0 4  was added before vortexing. Samples were left at 
room temp for 30 mins to allow oxidation to occur before cooling in ice for 
10 mins. Ice cold 10% ZnSC^ (300ul) was added followed by lOOul of 1.4M 
NaOH and the tubes centrifuged for 10 mins at lOOOg using a Heraeus 
Biofuge A bench-top centrifuge. An aliquot of the supernatant (700ul) was 
removed and 1ml of formaldehyde detection reagent (2M ammonium 
acetate, 0.02M acetylacetone) was added to this. All tubes were tightly 
sealed and incubated at 37<>C for 60 mins in a Griffin 100 Series waterbath. 
The samples were incubated at room temp for 10 mins before reading the 
fluorescence emission at 510nm after excitation at 410nm (slit width=10nm, 
fix scale=1, photomultiplier gain=1 and sensitivity=3) using a LS5-B Perkin-
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Elmer Luminescence Spectrometer. In some cases the absorbance at 
412nm was measured using a PYE Unicam SP6 Spectrophotometer. A 
calibration graph for fructose standards (0-50nmols) was also prepared as 
shown in fig 2.4. All assays were performed in duplicate and the results 
expressed as moles AP/mole protein.
2.8.2: Periodate Oxidation/DDL Microassay
A microversion of the periodate method of Gallop et al (43) was developed 
in this project. The volume of sample or standard was adjusted to 40ul with 
water and incubated with 20ul of 0.1 M HCI and 20ul of 0.05M sodium 
periodate at room temp for 30^mins. To terminate oxidation, samples were 
cooled in ice for 10 mins and mixed with 20ul of 15% ZnS0 4  and 20ul of 
0.7M NaOH. Both reagents were precooled and samples were vortexed 
throughout addition. They were then centrifuged for 10 mins at 9,000g to 
remove precipitated ZnlÜ4, and lOOul aliquots of the supernatant fluid were 
transferred to microplate wells. Formaldehyde detection reagent (FDR) was 
freshly prepared by mixing 46ul of acetylacetone in 10ml of 3.3M 
ammonium acetate; 200ul of this reagent was added to each well and 
mixed thoroughly with sample using the microplate mixer and 
diacetyldihydrolutidine (DDL) allowed to develop by incubating for 1 hour at 
37°C. Reagent blanks (lOOul water + 200ul FDR) were incubated at the 
same time. The microplate was inserted into the microplate reader and 
absorbance of reagent blanks at 405nm subtracted automatically from 
absorbance of sample solutions. A calibration graph using 0-50nmols 
fructose was also prepared (fig 2.5). All assays were performed in duplicate 
and the results were expressed as moles AP/mole protein.
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2.8.3: Thiobarbituric Acid (TBA) Microassay
A microversion of the TBA method of Parker et a! was used (144). To lOOul 
of sample or of standard in bijoux bottles was added lOOul of 0.5M oxalic 
acid. The bottles were tightly sealed and incubated in a Tefal pressure 
cooker at 124°C and 124 KPa. After allowing the samples to cool for 15 
mins at room temp, they were transferred to eppendorf tubes followed by 
addition of lOOul of 40% trichloroacetic acid (TCA). The samples were 
centrifuged at 9,000g for 10 mins and 200ul aliquots of the supernatant 
were transferred to microplate wells. To these aliquots, 67ul of 0.05M TBA 
(which has been adjusted to pH 6 with NaOH) was added to each well and 
mixed thoroughly. Microplates were incubated at 37oc for 30 mins to allow 
chromophore to develop and allowed to cool to room temp for a further 15 
mins. Standards of 0-50nmols fructose were prepared simultaneously with 
each assay (fig 2.6). Absorbance at 450nm was measured using the 
microplate reader. All assays were performed in duplicate and the results 
expressed as nmols HMF/mg protein.
2.8.4: Dinitrophenylhydrazine (DNPH) Microassay
A modified version of Fields and Dixon was used (145). To 0.5ml of protein 
or standard ketone solution made in distilled water was added 0.24ml of 
10M HCI, followed by 0.1ml of 5mM dinitrophenylhydrazine prepared in 2M 
HCI. The tubes were vortexed and left at room temp for 30 mins before 
transferring 0.3ml aliquots to microplate wells. Absorbance at 405nm was 
measured in the microplate reader. A calibration graph was prepared using 
0-50nmol ketoglutarate standards (fig 2.7). All assays were performed in 
duplicate and the results expressed as moles carbonyl/mole protein.
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2.8.5: Phenylboronate Affinity Chromatography
This method was adapted from that of Middle et al (146). A 200ul sample 
containing 2mg albumin in washing buffer (0.25M ammonium acetate, pH 
8.5 containing 0.05M magnesium acetate and 3mM sodium azide) was 
applied to a 1 X 2cm column packed with Matrex PBA-10 resin (Amicon 
Corp, Danvers, MA, USA). After washing to remove unadsorbed protein, 
glycated albumin was eluted in washing buffer containing 0.25M sorbitol. 
Flow rate was maintained at 25ml/hour using a LKB 2120 Varioperpex II 
pump and the A279 was monitored by a LKB 2138 Uvicord 8  connected to a 
LKB 2065 Chopper-bar recorder. The column was regenerated in 0.1 M 
acetic acid. The results were expressed as percentage glycation.
2.8.6: Serum Fructosamine Assay
This assay was kindly performed by Dr Martin Hartogg, Department of 
Medicine, Southmead General Hospital, Bristol, UK and is according to the 
procedure of Johnson et al (45).
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2.9: Measurement of AGE
Sugar-induced AGE on proteins can be fluorescent and / or crosslinked and 
these properties were used to detect them;
2.9.1 : Fluorescent-AGE
The procedure of Suarez et al was used (99). Proteins were diluted in water 
to approximately 1 mg/ml and fluorescence emission at 420nm was 
measured after excitation at 350nm using either a LS5-B Perkin-Elmer 
Luminescence Spectrometer (fix scale=1, slit width=10nm) or an Aminco- 
Bowman (model J4-8960) Spectrophotofluorometer (emission slit=1mm, 
excitation slit=2mm). The latter fluorimeter was calibrated daily using a 
quinine sulphate solution prepared by dissolving quinine sulphate (1 ug/ml) 
in 0.1 M H2SO4. A plot of fluorescence against concentration of glycated 
protein (0-5mg/ml) was prepared to check limits of linearity (fig 2.8). The 
glycated BSA was prepared by incubating BSA (6 mg/ml) in 0.5M glucose 
or fructose for 16 and 11 days respectively at 37°C in 0.05M sodium 
phosphate buffer/3mM sodium azide, pH 7.4 (section 2.1). All 
measurements for samples were made in duplicate and the results 
expressed as either arbitrary units/mg protein or as relative fluorescence.
2.9.2: Crosslinked-AGE
These AGE were detected by their crosslinking on SDS gels after 
electrophoresis. Gels were stained with Coomassie Blue R and bands were 
quantified using laser densitometry.
The crosslinking was expressed as percent oligomer and calculated from;
sum of intensities of polymer bands x 100 
sum of intensities of polymer + monomer bands
Other gels were silver stained for a 100 fold greater sensitivity and used to
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detect fragmentation products.
SDS Polyacrylamide Gel Electrophoresis: SDS gels (10%) were 
prepared according to the method of Laemmli (147). An LKB vertical slab 
gel electrophoresis cell was used to make gels of size 14 X 18cm and 
1.5mm thick. The constituents required to make a 10% gel were;
Resolving gei: 10% acrylamide, 0.33% bisacrylamide, 0.375M Tris-HCI, 
pH 8 .8 , 0.1% SDS, 0.075% ammonium persulphate and 50ul TEMED per 
100ml of resolving gel solution.
Stacking gei: 3.75% acrylamide, 0.1% bisacrylamide, 0.125M Tris-HCI, 
pH 6 .8 , 0.1% SDS, 0.075% ammonium persulphate and 75ul TEMED per 
100ml of gel solution.
The resolving gel solution was applied between the plates till the level was 
approximately 2/3 the way up and then a small layer of water was poured 
on top. The gel was allowed to polymerize for 30 mins before pouring off the 
water. Stacking gel was layered on top and the combs inserted. The gel 
was allowed to set overnight at 4^0.
Sample preparation: Protein sample was treated with an equal volume, 
of sample buffer (0.125 M Tris-HCI, pH 6 .8 , 4% SDS, 20% glycerol, 10% 2- 
mercaptoethanol and 0 .002% bromophenol blue) and boiled at 100°C for 5 
mins. Concentration of protein was adjusted so that there was 
approximately 2mg/ml after diluting with sample buffer. In experiments in 
chapter 9, the sample buffer was 0.05M potassium phosphate, pH 7.4, 5% 
dithiothreitol and 2% SDS.
Markers: Molecular weight markers ranging from 14 to 66KD (stock no 
SDS-6 ) were used for lysozyme and RNase gels whereas for albumin the 
markers ranged from 29 to 205KD (stock no SDS-6H). Both markers were 
from Sigma, Poole, Dorset, UK.
Electrophoresis: Samples of volume lOul were loaded in the sample
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wells followed by 50ul of the running buffer (0.025M Tris, 1.92M glycine, 
and 1% SDS, pH 8.3). The electophoresis cell was placed in a LKB 2001 
vertical electrophoresis unit attached to a cooler (LKB 2209 Multitemp). 
Using a LKB 2197 power supply, 150V was applied for 5 hours.
Fixing of geis: Coomassie Blue R staining, gels were fixed in 10% TCA 
overnight whereas for silver staining, gels were fixed in 50% ethanol and 
10% acetic acid overnight.
Coomassie Biue R staining: Gels were gently stirred for 30 mins in 
Coomassie Blue R stain (0.25% Coomassie Blue R, 9.2% acetic acid and 
45.4% methanol). Gels were destained in 7% acetic acid and 5% methanol 
with several changes.
Siiver staining: After fixing the gels overnight, they were transferred to a 
dish containing 10% gluteraldehyde for 30 mins with gentle shaking. The 
gels were then rinsed In distilled water for 20 mins followed by rinsing in 
15% ethanol with 3 changes over 10 mins. Gels were soaked for 10 mins in 
silver solution (0.077% NaOH, 0.014% NH3OH and 0.78% AgNOa). For 6 
mins, gels were washed in distilled water and then placed in developing 
reagent (0.001% formaldehyde, 9.5% ethanol and 5% citric acid) for 10-15 
mins till the bands became visible. To stop development, gels were rinsed 
in distilled water and stored in 15% ethanol.
Photography: Gels were photographed using a Ilford PanF ISO 50 B&W 
film (Ilford Ltd, Mobberley, Cheshire, UK) in a Cannon A1 camera with a 
Cannon FD lens 50mm f/1.4. The prints were developed on llfospeed 5 
photographic paper to give a good contrast.
Scanning of Gels: Gels were scanned using a LKB Ultroscan XL laser 
densitometer and dried using an LKB 2003 slab gel dryer.
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2.10: Chemicals and Reagents
The Chemicals and reagents used in this work were obtained from the 
following sources;
Proteins
Lysozyme (egg white)
Ribonuclease A
Collagen (bovine achilles tendon type I) 
Human serum albumin (fatty acid free) 
Bovine serum albumin (fatty acid free)
Bovine serum albumin (fraction V)
Enzymes
Collagenase
Proteinase K
Chemicals
N-acety-L-lysine-N-methylamide 
Aminoguanidine 
N-acetyl-L-cysteine 
Thiobarbituric acid 
Coomassie Blue R 
Trinitrobenzene sulphonic acid
Sigma Chemical Company, 
Poole,
Dorset (UK).
BDH Limited,
Poole,
Dorset (UK).
Sigma Chemical Company, 
Poole,
Dorset (UK).
Boehringer Manheim, 
Lewes,
East Sussex (UK).
Acetylsalicylic acid 
L-lysine
Sodium cyanoborohydride
Galactose
Sorbitol
Ketoglutaric acid
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All of the above chemicals were obtained from;
Sigma Chemical Company,
Poole,
Dorset (UK).
All other reagents were of the highest purity available (Analar grade) and 
obtained from;
BDH Limited,
Poole,
Dorset (UK).
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CHAPTER 3
Development of Glycatlon Microassays
3.1 : Introduction
Measurement of glycated proteins such as Hb and albumin is of interest in 
clinical laboratories for the assessment of blood glucose control in diabetics. 
Glycation of long lived proteins such as collagen has been implicated in the 
secondary complications of diabetes and ageing and measurement of such 
proteins is of interest in research laboratories.
In this project model proteins such as albumin, lysozyme and ribonuclease 
were used and my requirements for a glycation assay were that it should; (i) be 
suitable for absolute values and reproducible, (ii) require only small amounts of 
protein, (iii) be suitable for large numbers of samples and (iv) be relatively 
simple and inexpensive. Of the glycation assays listed in section 1.8 of chapter 
1, the fu rosi ne method is unsuitable since it requires a HPLC column and has a 
poor yield of only 30%. The borohydride method is laborious, non specific and 
unsuitable for large number of samples. The resins required for the 
phenylboronate method are expensive and electrophoretic methods are only 
suitable for Hb.
Of all the simple colorimetric assays for glycation, the periodate method has the 
advantage in that it is stoichiometric and suitable for absolute values. It 
quantifies the formaldehyde (HCHO) released by periodate oxidation of C-1 
hydroxyls in the AP form of glycated protein.
Amador: product ------- ► H C H O -------- ► chromophore (DDL)
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This HCHO is converted to the chromophore diacetyldihydrolutidine (DDL) and 
in the original method of Gallop et al (43) , this was detected fluorimetrically. 
The original Gallop procedure requires a fluorimeter, between 1-5mg of protein 
per assay tube, has a yield of DDL (determined in this study) of less than 70% 
and the calibration graph is linear only upto 40 nmols of DDL. The assay is time 
consuming especially when large numbers of samples are to be processed and 
this is probably one of the major reasons why the procedure is not in use in 
routine clinical laboratories. Theoretically there are a number of factors which 
could affect yield of DDL; (i) inadequate oxidation of AP to HCHO, (ii) loss of 
HCHO during removal of protein in the zinc sulphate precipitation step and (iii) 
inadequate conversion of HCHO to DDL. These factors were investigated and 
the procedure was modified to improve yield of DDL. The procedure was also 
scaled down and adapted for use with a microplate reader.
Another colorometric assay, the TBA method has been used in some routine 
laboratories but has largely been discontinued since it is time consuming, 
cumbersome and unlike the periodate assay is non-stoichiometric and therefore 
only suitable for comparative purposes and not absolute values. However, 
unlike the periodate assay, the TBA method can be used to measure glycated 
collagen since collagen crosslinks interfere in the former assay. Although the 
TBA method has been superseded by other methods for assaying glycated Hb 
and albumin, it is still a simple, convenient and inexpensive method for 
measuring glycated collagen. It has advantages over the furosine method for 
assaying glycated collagen in that it is simpler, does not require expensive 
equipment or reagents and is faster and more appropriate for processing large 
numbers of samples. Furthermore, the protein does not have to be hydrolysed 
to its constituent amino acids. The TBA assay requires some 10mg of protein
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and the yield of HMF varies between 10% (42) to 80% under optimum 
conditions (148) and depends critically on the protein concentration (149). In 
the initial stages of this project I was intending to work on collagen (which 
unfortunately had to be abandoned later) and required a simple rapid assay for 
measuring glycation. The autoclave version of the TBA method of Parker et al 
was chosen since it has the advantage in that it only requires one hour of 
boiling compared to earlier versions which involved between 4-6 hours and 
therefore were very time consuming (144). This Parker method was further 
modified to increase sensitivity and yield of HMF and the method was adapted 
for use with a microplate reader so that it was faster and less cumbersome. All 
these objectives were achieved to give a simple, rapid microassay suitable for 
measuring glycation of collagen as well as other proteins. Free sugar will 
interfere in the TBA method and have to be removed prior to assay. 
Glycoproteins with acid labile glycosidic bonds have been reported to interfere 
in this assay (42) and present a major problem in interpreting results.
3.2: Aims
1 : To determine and improve yields of DDL in the periodate assay of Gallop
et al by investigating the different steps at which losses may occur using its 
published molar absorbance.
2: To improve the speed and sensitivity of the periodate assay by minimising
quantities and adapting for use with a microplate reader.
3; To improve the speed and sensitivity of the TBA method of Parker et al by
minimising quantities and adapting for use with a microplate reader.
4: To investigate the relationship between protein concentration and
absorbance of chromophore using a defined glycated protein for both TBA 
and periodate microassays.
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5: To determine the correlation coefficient between the periodate and TBA
microassays and compare the apparent exterit of glycation of HSA by both 
assays.
3.3: Experimental Protocol 
In Vitro Glycation: Fast glycation involved incubating collagen (40mg/ml) 
and BSA Fatty acid free (10mg/ml) in 0.5M glucose for upto 20 days at 37°C in 
0.05M sodium phosphate buffer/3mM sodium azide, pH 7.4 (section 2.1). 
Unbound sugar and labile SB were removed by extensive dialysis against 
water (section 2.2). Collagen was digested (section 2.3) and both proteins 
stored frozen.
Protein Concentration: This was determined using the Pierce BOA protein 
assay reagent (section 2.4.2).
Yield of DDL in Periodate Method: Fructose standards prepared in 
distilled water were treated exactly as in the original method of Gallop et al 
(section 2.8.1) or as in the new microassay (section 2.8.2). Formaldehyde 
standards were also prepared and incubated directly with the detection reagent 
(FDR). The yield of DDL for standards treated according to the Gallop procedure 
was determined by measuring the absorbance at 412 nm on a PYE Unicam 
Spectrophotometer using molar absorbance of DDL as 8,000 I mol-^cm-i (44). 
The nearest wavelength of the filter for microplate reader was 405nm, and using 
the spectrophotometer to compare the absorbance at 412nm and 405nm, the 
molar absorbance at 405nm was calculated as 7780 I mol-icm T This value 
was used to determine yield of DDL in the microassay.
Yield of HMF during Hydrolysis in the TBA Microassay: Two sets of 
HMF standards were prepared and treated exactly the same (section 2.8.3) 
except that in one set the heating step was omitted. Assuming complete
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conversion of HMF to chromophore, the difference in the absorbance values for 
the chromophore between the two sets was used to calculate the percentage of 
HMF lost during heating.
3.4: Results
A linear relationship was obtained when the absorbance at 412nm for DDL was 
plotted against number of moles of fructose as shown in fig 3.1 The yield of DDL 
from fructose was calculated as 67.5% using its molar absorbance as 8,000 I 
mol-icm-i (tab le3.1).
A linear relationship was also obtained when chromophore was produced 
directly from HCHO in the same method (fig 3.1) and the yield of DDL from 
HCHO was 100% (table 3.2) suggesting that this second step of the assay goes 
to completion.
For the periodate microassay, there is a linear relationship between the 
production of DDL and fructose or HCHO standards (fig 3.2) and the yield from 
fructose is now over 90%.
In the TBA microassay, the loss of HMF during 1 hour hydrolysis was no greater 
than 13% ie; I-
HMF standards (nmols) Percentage loss of HMF
10 11
30 13
50 12
The coefficient of variation (CV) of a method refers to the size of the random 
errors and the reproducibility of the measurements (ie the ability to provide the 
same value on multiple analysis). As the CV improves, its value approaches
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zero. Using HSA, the extent of glycation was determined by both methods (table 
3.3) and the CV calculated.
In the range 0-0.3mg of protein per well, absorbance was linear with 
concentration of g located BSA for the periodate microassay (fig 3.3). Using 
glucated collagen (0-2mg), a linear relationship was also obtained for protein 
concentration against absorbance in the TBA microassay (fig 3.4).
A correlation coefficient (r) of 0.94 was obtained for 22 BSA samples glucated to 
different extents in vitro when measured by the periodate and TBA microassay 
(fig 3.5).
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Fructose standards 
(nmols)
Observed DDL 
(nmols)
Percentage yield of 
DDL
10 6.75 67.50
20 13.50 67.50
30 20.25 67.50
40 27.00 67.50
50 33.75 67.50
Table 3.1 : Percentage yield of DDL from fructose standards (0-50nmols) in the
periodate assay (Gallop procedure)
HCHO standards 
(nmols)
Observed DDL 
(nmols)
Percentage yield of 
DDL
10 10.13 100
20 20.25 100
30 30.38 100
40 40.50 100
50 50.60 100
Table 3.2: Percentage yield of DDL from HCHO standards (0-50nmols) in the
periodate assay (Gallop procedure)
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Sample P.l (moles/mole) TBA (moles/mole)
1 0.45 0.35
2 0.44 0.36
3 0.44 0.37
4 0.44 0.35
5 0.45 0.35
Mean 0.44 0.35
S.D 0.005 0.008
C.V 1.1% 2.25 ’
Table 3.3: In vivo glycation of HSA (expressed as moles AP/mole protein) as 
measured by the periodate and TBA microassays. The results are given as 
mean +/- SD (n=5).
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3.5: Discussion
In this study, I report use of the periodate method in conjunction with a 
spectrophotometer whereas the original Gallop procedure relied on use of a 
fluorimeter. Fructose resembles the AP form of glucated protein in having a C-2 
carbonyl group in the straight chain configuration, but existing predominantly in 
the ring form. Like the AP, it liberates 1 mol of HCHO per mole on periodate 
oxidation, and can therefore be used as a standard for the AP. In the Gallop 
procedure, the calibration graph is linear upto 40nmols of fructose and then 
starts to deviate from linearity, presumably due to quenching (fig 2.4, chapter 2). 
No such deviation is seen when DDL is measured by its absorbance, and the 
graph is linear upto SOnmols (fig 3.1 ) and above (not shown). Yield of DDL from 
fructose standards was 67% (table 3.1), and theoretically this yield may be 
reduced at any of 3 stages;
1 : by incomplete oxidation and cleavage of C-1 to produce HCHO
2: by adsorption or trapping of free HCHO in the zinc periodate precipitate
3: by incomplete conversion of HCHO to DDL
The yields of DDL in this last step were measured by incubating standard 
HCHO solutions with FDR (table 3.2). A 100% yield of DDL from HCHO was 
obtained and this suggests that loss of HCHO occurs during oxidation and/or 
centrifugation. The procedure of Gallop et al was scaled down keeping 
everything in the same proportion so that it could be used with a microplate 
reader. Fig 3.2 shows that with the microassay procedure, absorbance is linear 
for 5-40nmols of fructose per well. As little as 2nmol can be readily detected 
(giving absorbance readings of 0.04). Concentrations below this are not 
detected probably due to the short path length calculated as 0.88cm per 300ul 
of solution and also due to the yield of HCHO from fructose. Loss of HCHO in
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the zinc periodate precipitate has been reduced by increasing speed of 
centrifugation from 1000g in the Gallop procedure to 9000g in my microassay. A 
greater proportion of HCHO containing solution can thus be removed as 
supernatant liquid and converted to DDL. This modification allowed the overall 
yield (from fructose to DDL) from 67% with the Gallop procedure to 90% with the 
microassay. This compares favourably with yields in other methods eg 30% for 
the furosine assay (42) and 80% for the TBA assay under optimum conditions 
(148). The sensitivity of the assay has been improved by ten fold ie requires 
only 0.1 mg of protein compared to at least Img required by the Gallop 
procedure. Furthermore a fluorimeter is no longer required and since the DDL is 
being measured by its absorbance, the calibration graph is linear upto 
lOOnmols of fructose. Free sugars and SB interfere in the periodate assay but 
can be eliminated by extensive dialysis prior to assay. Glycoproteins will not 
interfere in this assay unless they carry chain terminal reducing sugars or sialic 
acid derivatives.
In the range of 0-0.3mg of protein per well, absorbance was linear with 
concentration of glucated BSA (fig 3.3) and the CV of 1.1% compares 
favourably with the CV of 2.2% obtained with the Gallop procedure (43).
The TBA method of Parker et al has been modified and adapted for use with a 
microplate reader. The nett amount of HMF available for chromophore formation 
depends on the balance between its production and loss during the heating 
process. Parker et al reported 30% destruction of HMF after 1 hour of heating in 
an autoclave whereas in the microassay no more than 15% loss of HMF 
occurred. Furthermore, HMF yield also varies with the amount of protein used 
and is greater with less protein (149). Since the microassay only requires Img 
of protein compared to 10 mg in the Parker method a better yield of HMF would
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be expected. Using in vitro glucated collagen, it was found that in the range 0- 
2mg, absorbance was linear with concentration of protein. A CV of 2.25% is 
obtained with the TBA microassay and this compares with the CV of 1.65% 
obtained with the Parker method (144).
Extent of glycation of HSA measured by both TBA and periodate microassays 
were compared to that in the literature ie;
S tudy Method Moles AP/mole
Schleicher et al (90) Furosine 0.24
Baynes et al (150) Borohydride 0.29
Olufemi et al (151) Periodate 0.37
Walton et al (152) Periodate 0.49
This study Periodate 0.44
This study TBA 0.36
HSA was chosen in this study since it is easy to compare values obtained by 
these assays with those in the literature. The value of 0.44 moles/mole of 
protein compares well with that obtained by the Walton group using the original 
method of Gallop et al. The value obtained by the TBA microassay also 
compares favourably with the other methods. A correlation coefficient (r) of 0.94 
was obtained for the two methods which suggests that the periodate microassay 
compares well with the more established TBA method. Both microassays have 
the advantage that they are faster to perform ie with the microplate reader upto 
94 samples can be read in 40 seconds in the last step and less reagent is 
required therefore saving costs. The periodate microassay was chosen for my 
work since it is stoichiometric, more reproducible than the TBA method and 
takes less time to perform.
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CHAPTER 4
Glycation and AGE Formation in Proteins by 
Different Sugars
4.1 : Introduction
Almost all the other reducing sugars are more reactive than glucose but have 
not been thoroughly investigated because of their minute concentrations in 
vivo. The study of these sugars is important since their rarity could be 
compensated by their greater reactivity. Under certain circumstances, levels of 
these sugars may be high eg high levels of galactose during galactosaemia. 
Comparative studies so far have looked at differences in the rate of SB 
formation and to my knowledge a comprehensive study on the differences in 
rates of AP and AGE production have not yet been undertaken. Such 
comparative studies may provide an insight into how structural differences 
between sugars may affect rates of the Maillard reaction and could raise new 
questions regarding the role of these other sugars in ageing and diabetic 
complications,
Using radiolabelled sugars, Bunn et al have shown that the initial reaction (ie 
SB formation) between a protein and sugar depends on the percentage of 
sugar in the acyclic form and on the reactivity of its carbonyl group (11). Also 
the reaction rate is inversely proportional to the number of 0  atoms in the 
sugar, being lowest for hexoses and highest for trioses like glyceraldehyde. 
Taking the above considerations into account then the order of SB formation by 
the four sugars used in this study would be expected to be ribose then fructose, 
galactose and glucose. Indeed this is the case and has already been 
demonstrated by Bunn et al (11). In this chapter rates of AP and AGE formation 
after incubating BSA in different sugars were compared to determine whether
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the order of AP and AGE formation by different sugars was similar to their order 
of SB formation. The rate of AP formation after glycation of BSA in vitro by 
different sugars was measured using the periodate microassay. Sugars which 
have the highest comparative rates for AP formation might be expected to have 
similar comparative rates for fluorophore formation. However this assumes that 
post-Amadori reactions are the same for proteins glycated by different sugars 
and this is very unlikely.
The reactivity of free amino groups within a protein can also vary depending on 
their accessibility within the protein structure and on their pK. Furthermore 
certain amino groups are more susceptible to glycation because they are 
adjacent to acidic groups (12) which can catalyse the Amadori rearrangement. 
Since it is known that the susceptibility of different proteins to glycation may 
vary, the effect of different sugars on fluorescence formation in other proteins ie 
lysozyme and RNase was also investigated. The susceptibilty of a protein to 
form different types of AGE ie fluorescent or crosslinked could vary ie some 
proteins may form crosslinks more readily than others and vice versa. To 
investigate whether this was true, equimolar concentrations of lysozyme and 
RNase were ribated under identical conditions and then compared for 
crosslinking and fluorescence formation.
High non-physiological concentrations of sugars have been used in this study 
because glycation and the Maillard reaction are slow processes and use of 
lower concentrations would have demanded increased incubation periods with 
a higher probability of bacterial contamination. BSA, lysozyme and RNase 
were chosen as model proteins because they are soluble, relatively 
inexpensive and already well characterised with respect to glycation.
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4.2: Aims
1: To determine whether the comparative rate of AP formation by different
sugars was similar to their known rates of SB formation, using BSA as a 
model protein in vitro.
2: To determine whether rate of fluorescence generation by different sugars
in vitro was similar to their known rates of SB formation, using BSA as a 
model protein.
3: To determine whether crosslinked and non-crosslinked-AGE form
independently of each other, crosslinking and fluorophore formation in 
lysozyme and RNase was compared.
4: To investigate whether the effect of different sugars on fluorescence
generation is similar to their effect omcrosslinking using lysozyme and 
RNase as model proteins.
4.3: Experimental Protocol 
In Vitro Glycation: BSA fraction V (10, 20 and 40mg/ml), lysozyme 
(lOmg/ml) and RNase (5mg ml) were incubated at 37°C in 0.5M sugar for upto 
16 days in 0.05M sodium phosphate buffer/3mM sodium azide (section 2.1). 
Equimolar concentrations (2mM) of lysozyme and RNase were also incubated 
in 50mM ribose for upto 10 days under the above conditions. Proteins were 
dialysed against distilled water (section 2.2) and stored frozen.
Protein Concentration: This was determined using the Pierce BOA protein 
assay reagent (section 2.4.2)..
Measurement of Glycation: AP levels in glycated BSA were measured 
using the periodate microassay (section 2.8.2).
Measurement of AGE: AGE were measured by their crosslinking on SDS 
gels (section 2.9.2) or fluorescence (section 2.9.1).
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4.4: Results
The periodate method used to measure extent of glycation of BSA induced by 
the different sugars quantitates only the AP since the labile SB has been 
removed by extensive dialysis prior to assay. Extent of ribation of BSA after 15 
days of incubation was almost 4 times greater than g location (fig 4.1). The 
order in which the sugars form AP is ribose > glucose > galactose > fructose 
(fig 4.1) and the increase in AP levels as a function of time is biphasic.
Solutions of BSA incubated in sugars developed a yellow colour which 
gradually darkened and became brown with time. In prolonged incubations 
over several months a dark brown precipitate was detectable at the bottom of 
tubes (results not shown). The order in which the different sugars caused these 
visible changes was ribose > fructose > galactose > glucose.
BSA incubated in all the different sugars generates fluorescence with the 
characteristic emission spectra described previously by Suarez et al (99). In 
the absence of sugar no rise in fluorescence is detectable suggesting that 
fluorescence is sugar-induced (see chapter 7 later). Rate of fluorescence 
formation is highest with ribose but unlike the rates of AP formation, the order of 
reaction is ribose > fructose > galactose > glucose (fig 4.2). In the ribose and 
fructose incubations nearly all the fluorescence is generated during the first 7 
and 10 days respectively after which the fluorescence yields appear to reach 
saturation. In contrast, a more gradual increase in fluorescence occurs with 
glucated and galactated BSA which seem to be heading for the same 
saturation values.
In fig 4.3, in vitro glycation of BSA reduces its electrophoretic mobility and a 
broadening of the protein staining band occurs particularly with fructose. Under
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these conditions, little or no polymerisation is seen. The BSA used was fraction 
V and contaminants ie mainly globulins are also visible on gel.
The order of fluorescence generation by the four sugars with lysozyme (fig 4.4) 
and RNase (fig 4.5) is similar to that for BSA ie ribose > fructose > galactose > 
glucose. Again fluorescence formation for both proteins incubated in ribose or 
fructose reaches saturation after about 7 days. For both lysozyme and RNase 
incubated in glucose and galactose, there appears to be a lag phase for 7 days 
before a rise in fluorescence occurs. Fig 4.6 shows the fluorescence generated 
by equimolar concentrations of lysozyme and RNase incubated in ribose. 
Fluorophores generated by ri bated RNase form twice as fast as those by 
ri bated lysozyme. However, when crosslinking of ri bated lysozyme on SDS 
gels (fig 4.7) and ri bated RNase (fig 4.8) was quantified, it was found that 
lysozyme crosslinked faster than RNase (fig 4.9). The polymerisation of 
lysozyme was 25% higher than that of RNase after 10 days of ribation whereas 
the fluorescence is only 46% of that generated by RNase. For lysozyme, a 
small percentage of protein (2-3%) was crosslinked in the controls even at zero 
time (fig 4.7) despite boiling of samples in mercaptoethanol prior to 
electrophoresis. Initially this crosslinked lysozyme was believed to be due to 
incomplete reduction of disulphide bonds. However, even treatment of samples 
using twice the concentration of mercaptoethanol (taken fresh from stock just 
before boiling) and increasing the period of boling to 10 mins did not reduce 
this crosslinking. Similar crosslinking of lysozyme can also be detected in gels 
quantified by Shin et al (18). This value was therefore subtracted from the rest 
to correct for sugar-derived crosslinking.
The order in which different sugars induced crosslinking was studied using 
lysozyme and RNase since these proteins crosslink readily. For RNase, the
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order in which the sugars induced crosslinking was ribose > fructose > 
galactose > glucose ie similar to that for the fluorescence. Fig 4.10 shows the 
gel for RNase glycated by different sugars for 12 days whereas fig 4.11 is the 
similar gel for lysozyme. Extensive glycation of RNase or lysozyme results in 
protein precipitation due to the formation of mellanoidins. Initially these were 
removed by centrifugation and the supernatant used for SDS-PAGE. Obviously 
this does not give a realistic representation of the true extent of crosslinking. 
For this reason, proteins were incubated for shorter periods of time so as to 
prevent formation of mellanoidins. No precipitation of protein glycated by 0.5M 
sugar for upto 12 days was detectable under the conditions used. RNase does 
not polymerise readily like lysozyme to give discrete oligomers ie there is a lot 
of protein between the bands for oligomers especially for ribated RNase (see 
fig 4.10). This is probably due to impaired SDS binding causing reduced 
electrophoretic mobility which is particularly high for ri bated proteins since they 
are more extensively glycated. The portion of streak in lane F (fig 4.10) labelled 
monomer is of protein less than the molecular weight of dimer. These gels 
were quantified and the results are given in table 4.1. The figure of 45% 
polymerisation for ribated RNase is therefore only an approximation.
For lysozyme the order in which the sugars induced the highest crosslinking 
was fructose > ribose > galactose > glucose ie fructose appears to be a more 
powerful crosslinking reagent. This compares with the fluorescence results 
were ribose is clearly the most potent inducer of fluorescence.
The experiments were repeated twice (n=2) and similar results found each 
time. The most representative results are shown. Since the conditions for the 
experiments were not always identical, it has not been possible to analyse the 
results statistically.
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Fig 4.1 : Apparent rates of AP formation after in vitro glycation of BSA
(20mg/ml) by 0.5M sugar
Page 83
1200 -
O)
E
w
0)uc0)o
(A(D
v _O3
LL
0.0 5.0 10.0 15.0
□ Cent 
o Gluc 
•  Fruc 
A Gai 
■ Rib
Period of incubation (days)
Fig 4.2: Fluorescence of BSA (10mg/ml) incubated in 0.5M sugar
Page 84
KD
t
+ 66
-  O
A B O  D E  F G H  
Fig 4.3: SDS-PAGE of BSA (40mg/ml) glycated in vitro for 16 days by 0.5M 
galactose (lanes B-C), fructose (lanes D-E) or glucose (lanes F-G). Non 
glycated BSA (lanes H-l) and marker for BSA (lane A) is also shown.
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Fig 4.4: Fluorescence of lysozyme (10mg/ml) incubated in 0.5M sugar
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Fig 4.5; Fluorescence of RNase (5mg/ml) incubated in 0.5M sugar
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Fig 4.7; SDS-PAGE of lysozyme (2mM) glycated in vitro by 50mM ribose for 0, 
2, 4, 6, 8 and 10 days (lanes B, C, D, E, F and G respectively). Also shown is 
lysozyme incubated in the absence of ribose for 0 (lane A) and 10 days (lane 
H).
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Fig 4.8; SDS-PAGE of RNase (2mM) glycated by 50mM ribose for 0, 2, 4, 6, 8, 
and 10 days (lanes B, C, D, E, F and G respectively). Also shown is RNase 
incubated in the absence of ribose for 0 (lane A) and 10 days (lane H).
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Fig 4.9: Crosslinking of lysozyme and RNase (2mM) incubated in 50mM ribose
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Fig 4.10: SDS-PAGE of RNase (5mg/ml) glycated in vitro for 12 days by 0.5M 
glucose (lane C), fructose (lane D), galactose (lane E) and ribose (lane F). Also 
shown is RNase incubated in the absence of sugar for 0 (lane A) and 12 days 
(lane B).
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Fig 4.11: SDS-PAGE of lysozyme (lOmg/ml) glycated in vitro for 12 days by 
0.5M glucose (lane C), fructose (lane D), galactose (lane E) and ribose (lane 
F). Also shown is lysozyme incubated in the absence of sugars for 0 (lane A) 
and 12 days (lane B).
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Protein Control G lucose Fructose Galactose Ribose
RNase 0 4.9 21.4 5.8 45.2
Lysozyme 0 15.3 41.3 31.4 38.6
Table 4.1 : Polymerisation of RNase and lysozyme glycated for 12 days by 0.5M
sugar
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4.5: Discussion
If the Amadori rearrangement was Identical for all sugars then their 
comparative rates of AP formation should be identical to their rates of SB 
formation. However, this does not appear to be the case in this study where the 
order of AP formation by different sugars is ribose > glucose > galactose > 
fructose (fig 4.1). There are two possible reasons for this. First post-Amadori 
reaction rates vary for different sugars for eg fructose has been reported to 
induce AGE formation upto 10 times faster than glucose probably due to 
greater reactivity of its aldehydic AP (99). As a result the steady state levels of 
fructose-derived AP may be low as they are rapidly converted to AGE. Greater 
reactivity of galactose-derived AP may also account for their low levels. 
Although galactose-derived AP would not be expected to be aldehydic in 
nature, a higher proportion may exist in the acyclic form compared to glucose- 
derived AP and therefore participate more rapidly in AGE formation. A second 
reason could be that AP derived from sugars other than glucose may not be 
detected by the periodate assay. Indeed, the fructose-derived aldehydic AP 
would not be expected to release HCHO upon periodate oxidation (99) and so 
in this study I am detecting less than half of the fructose-derived AP (see 
chapter 5 later). In contrast, galactose-derived AP would be expected to 
release HCHO upon periodate oxidation. Hitz et al have demonstrated using a 
radiolabelled technique that incorporatation of galactose occurs at a faster rate 
than glucose even after excluding SB for several proteins including albumin
(153). This group therefore suggested that galactose forms AP faster than 
glucose which would appear to conflict with my result. However, it is worth 
pointing out that sugars incorporated into AGE would also be measured with 
the radiolabelled technique but probably not detected by the periodate assay 
which accounts for the discrepancy between my results and those of Hitz et al.
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In the case of ribose it appears that all the AP are being detected, as would be 
expected theore tica lly . Another study using phenylboronate a ffin ity  
chromatography has also shown that ribose-derived AP form considerably 
faster than those from glucose (154). The expected chemical structures for 
glucose, galactose and ribose derived-AP are given below;
H .C -N H -P r
 ^ I
H jC -N H -P r
 ^ I
C^OH
H O -C -H
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H - C -O H
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CH2OH
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H -C -O H
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By applying the Malaprades rule (see section 1.8.2 and fig 1.10), all of these 
AP would be expected to yield HCHO after periodate oxidation. The C atom in 
HCHO would come from C-1 of these AP's. The ribose-AP is likely to be acyclic 
in nature and so would release a second HCHO from C-5 (compare to 
structures in fig 1.10). This could explain partly the higher values for glycation 
in fig 4.1. Fructose-derived AP will be discussed in chapter 5.
As an indication of sugar-induced damage in vivo, fluorescent-AGE might be 
better than the apparent AP. Protein fluorescence has been reported to 
increase during diabetes and ageing and has been related to the severity of 
diabetic complications (93). In vivo, glucose is believed to be the major sugar 
responsible for this fluorescence. The two recently characterised AGE namely 
pentosidine and pyrraline are both fluorescent in nature, and their levels have 
been reported to increase during diabetes (24, 28). Fluorescence generated by 
proteins upon incubation with sugars is due to buildup of AGE and not AP
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since selective removal of AP by periodate treatment has been reported to 
have no effect on protein fluorescence (99).
In th is study, incubation of BSA with the different sugars generated 
fluorescence in the order ribose >fructose >galactose >glucose ie similar to 
the ir expected rate of SB formation (fig 4.2). The rates of fluorescence 
generation is particularily high with fructose and ribose rapidly attaining 
maximum values within the first few days, followed by an apparent decline in 
the prolonged incubations possibly due to quenching. Other studies have 
shown that ribose induces faster fluorescence of lens crystallins than glucose
(154), and so too does fructose with BSA (99), lens protein (100), collagen 
(101) and RNase (57). The order in which the four sugars react with BSA to 
generate fluorescence is similar to that with lysozyme (fig 4.4) and RNase (fig 
4.5). It therefore seems that rate of fluorescent-AGE generated by proteins after 
reaction with different sugars will depend on the rate of SB formation 
irrespective of the protein used. For all three proteins fluorescence induced 
after ribation and fructation rapidly reaches saturation whereas the other 
sugars are probably aiming for saturation and therefore the sampling time may 
be important. For both lysozyme and RNase there is a lag phase for 
incubations in glucose and galactose. During this lag phase buildup of AP 
probably occurs giving rise to the increase in fluorescence seen after 7 and 5 
days for lysozyme and RNase respectively.
I found that BSA is not a good model protein for crosslinking studies since it 
does not readily polymerise. BSA is probably more susceptib le to 
intramolecular as opposed to intermolecular crosslinking. This is consistent 
with reports by Kato et al who too could not detect appreciable crosslinking of 
either BSA or FISA (155). In contrast, Sakurai et al, have suggested that
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glycated HSA is a good model protein for crosslinking studies and have shown 
extensive polymerisation of HSA on 5% SDS gels (54). In this case however, 
the glycated fraction was separated from non-glycated HSA by affin ity 
chromatography prior to electrophoresis. Glycated BSA does show reduced 
electrophoretic mobility which is particularly prominent with fructated BSA (fig 
4.3). This reduced electrophoretic mobility has also been reported for glucated 
RNase (55), and is probably due to impaired SDS binding to proteins.
Since BSA is not a good model for crosslinking, I decided to investigate other 
proteins namely lysozyme and RNase. Dyer et al have shown that less than 1% 
of crosslinks in glucated lysozyme are fluorescent which means that the major 
AGE responsible for crosslinking is non-fluorescent and colourless (26). The 
pathways for crosslinked and non-crosslinked AGE may therefore operate 
independently of each other. To test this hypothesis, I compared crosslinking 
and fluorescence of ribated lysozyme and RNase glycated under identical 
conditions. I was able to show that ribated RNase generates fluorescence 
much faster than ribated lysozyme (fig 4.6). However, the ribated lysozyme (fig 
4.7) crosslinked more readily than the RNase (fig 4.8 and 4.9). For this reason 
the effect of different sugars on crosslinking was undertaken to see how it 
relates to the fluorescence and AP formation rates.
Fructation-induced polymerisation of lysozyme is similar to that induced by 
ribation (table 4.1) and these results agree with those of Shin et al (18) who 
also showed that comparative rates of fructose and ribose-derived crosslinking 
of lysozyme were similar. This compares with the fluorescence studies where 
ribose-derived fluorescence was considerably higher for all proteins. A 
postulated intermediate of the Maillard reaction 3-DG is known to promote 
protein crosslinking in vitro, and it has been suggested (although not yet 
proven) that fructose may form this compound directly under physiological
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conditions in addition to that formed via the Amadori route (155). This could 
account for the higher crosslinking by fructose. It therefore seems that in 
contrast to fluorophore formation, crosslinking may not necessarily depend on 
the initial rate of SB formation.
Although ribose rapidly induces crosslinking and fluorophore formation, its 
level in the plasma is well below 50uM (28), and probably derived from 
turnover of ribonucleic acids. Galactose has been reported to induce SB (11) 
and AP (153) formation faster than glucose. However, to my knowledge this is 
the first report to demonstrate faster formation of AGE by galactose compared 
to glucose. Galactation has been well studied with respect to galactosaemia 
and at present there is no evidence that it contributes towards the undesirable 
effects in this disorder. Of these sugars fructose perhaps deserves the most 
attention since it can reach significant levels in vivo especially in diabetics. For 
this reason fructose has been selected and studied in depth in the remaining 
chapters of this thesis.
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CHAPTER 5
Fructose-Induced Glycation and AGE Formation
5.1: Introduction
In vitro studies have demonstrated that fructose is a more potent glycating 
agent than glucose (11) and upto 10 times more efficient at forming AGE (99). 
The possibility that fructose may contribute towards in vivo glycation has 
received little attention presumably due to its minute levels in the plasma. 
However, fructose is a permitted sweetener in diabetic foods and furthermore 
diabetics have been reported to have higher serum fructose levels compared 
to non-diabetic after ingestion of a fructose-rich diet (103). Increased activity of 
the sorbitol pathway in diabetes can lead to high levels of fructose in certain 
regions of the body notably those areas susceptib le to secondary 
complications (107). In these regions fructose levels can increase by 22 fold 
and one study has reported levels upto 12 mM in the lens (108).
At present there is direct evidence for modification of lens protein (57) and 
indirect evidence for modification of Hb (104) and collagen (113) by fructose in 
vivo. In the previous chapter, apparent fructose-derived AP levels were lower 
than those derived from glucose when measured by the periodate method and 
the possible reasons for this have been discussed in chapter 4. Most assays 
are designed to detect the glucose-AP and since the fructose-derived AP are 
different in structure they may not be detected by the various assays used to 
quantify glycation.
McPherson et al (57) have shown that approximately 85% of fructose-derived 
AP is attached to the protein via C-2 (fig 5.1). Fructose-derived AP attached to 
protein via C-2 may be theoretically an aldose (F-AP 1) or ketose (F-AP 2) 
although this has yet to be proved (99) (see fig 5.1). However this group also
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demonstrated that the remaining 15% of AP was identical to that formed by 
glucose (fig 1.1). This small amount of glucose-AP is probably formed from 
fructose since the two sugars have a common enediol ie
H2COH H C -O H  H C = 0
C = 0  C—OH H—C—OH
A i
Fructose Enediol Glucose
From theoretical considerations it would appear that other assays may also 
underestimate fructation. Assays commonly used in routine laboratories to 
measure glycation of serum proteins and Hb include the fructosamine and 
phenylboronate affinity chromatography methods respectively. These assays 
together with the TBA assay, often used to measure glycated collagen, were 
investigated to see whether they too underestimate fructation.
A common feature of all AP whether derived from glucose or fructose is the 
presence of a carbonyl group and an assay which can quantify this may 
provide a true estimate of fructation. The dinitrophenylhydrazine (DNPH) 
procedure used to assay free carbonyl groups has been used in earlier studies 
to quantify glycation of Hb (156) but was discontinued on the basis that a very 
small percentage of the glucose-derived AP exists in the acyclic form. 
However, in more recent studies this method has been successfully used to 
assay for glucation of albumin (157) and to quantify the reaction between 
glyceraldehyde and Hb (158). In this work an attempt was made to use this 
assay to estimate in vitro fructation of albumin.
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Fig 5.1 : Fructose derived Amadori products (adapted from ref (99))
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5.2: Aims
1: To compare the rates of fluorescence generation after in vitro glucation
and fructation using BSA as a model protein.
2: To compare the rates of glucose- and fructose-derived crosslinking using
lysozyme as a model protein.
3; Extent of fructation of BSA by the TBA, fructosamine and phenylboronate 
affinity chromatography methods was measured and compared to the 
values for glucated BSA in order to assess whether these assays like the 
periodate method underestimate fructation.
4: The DNPH assay detects free carbonyl groups and should detect all
fructose-derived AP therefore reflecting the true extent of fructation. This 
assay was used to measure and compare glucation and fructation of BSA.
5.3: Experimental Protocol 
In Vitro Glycation: BSA fatty acid free (tOmg/ml) was incubated in 0.5M 
sugar at 37°C for upto 24 days in 0.05M sodium phosphate buffer/3mM sodium 
azide, pH 7.4 (section 2.1). Aliquots were withdrawn after various time intervals 
and dialysed exhaustively against distilled water or column starting buffer (for 
the phenylboronate affinity chromatography assay) (section 2.2).
Protein Concentration: This was assayed using the Pierce BCA protein 
assay reagent (section 2.4.2).
Measurement of G lycation: AP levels were measured using periodate 
microassay (section 2.8.2), TBA microassay (section 2.8.3), phenylboronate 
affinity (PBA) chromatography (section 2.8.5), serum fructosamine (SPA) assay 
(section 2.8.6) and DNPH microassay (section 2.8.4).
Measurement of AGE: AGE were measured by their crosslinking on SDS 
gels (section 2.9.2) or their fluorescence changes (section 2.9.1).
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5.4: Results
Fig 5.2 shows the effects of in vitro glucation and fructation on fluorescence of 
serum albumin and clearly suggests that fructose has a greater effect on 
protein structure than glucose. Using lysozyme as a model protein for 
crosslinking, a similar result was obtained, with fructose-induced crosslinking 
being greater than that induced by glucose ( figs 5.3 and 5.4).
However, glycation assays would suggest the opposite (table 5.1). Glucose 
appears to produce some 3-10 times more AP than fructose, at each stage of 
the in vitro glycation.
Values for fructation measured by the TBA and fructosamine assay are less 
than 15% of those for glucation. In contrast fructose-derived AP levels 
measured by periodate and phenylboronate assays are between 30-40% of 
those for glucose-derived AP. Fig 5.5 shows moles of carbonyl groups per 
mole of protein formed by fructated and glucated BSA over a period of 16 days. 
The values for fructation are approximately 10 times higher than those for 
glucation. These experiments were repeated 3 tim es and the most 
representative results are shown.
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Fig 5.2: Fluorescence of BSA (10mg/ml) incubated in 0.5M glucose or fructose
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Fig 5.3: SDS-PAGE of lysozyme (10mg/ml) glycated in vitro by 0.5M glucose 
for 0, 2, 4 and 6 days (lanes A, B, 0  and D respectively) or 0.5M fructose for 0, 
2, 4 and 6 days (lanes E, F, G and H respectively).
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Fig 5.4: Crosslinking of lysozyme (lOmg/ml) incubated in 0.5M glucose or
fructose
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Periodate
(m oies/m oie)
TBA
(HM F/m g)
SFA
(mmoi/i)
PBA
(% )Time Period 
(days) G-BSA F-BSA G-BSA F-BSA G-BSA F-BSA G-BSA F-BSA
0 0.42 0.42 5.64 5.20 0.40 0.60 9.30 9.80
5 3.53 1.20 45.80 6.55 4.40 0.80 88.0 29.0
10 3.88 1.34 61.20 7.42 6.30 0.70 94.0 34.0
16 4.92 1.62 72.03 9.68 8.40 0.90 93.0 37.0
Table 5.1 : Apparent AP levels measured by different assays for BSA (lOmg/ml) 
glycated in vitro by 0.5M glucose (G-BSA) or fructose (F-BSA) for upto 16 days
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Fig 5.5: Protein bound carbonyl groups measured by the DNPH microassay for 
BSA (10mg/ml) glycated by 0.5M glucose or fructose.
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5.5: Discussion
Fructose-induced changes to protein structure occur much faster than those 
induced by glucose. Using BSA as a model protein, I have demonstrated that 
fructose forms fluorescent-AGE considerably faster than glucose in vitro (fig 
5.2). This finding is consistent with other studies for BSA (99) and indeed other 
proteins ie RNase (57) and collagen (101). S im ilarly fructose-derived 
crosslinks form faster than those induced by glucose and this was 
demonstrated using lysozyme as a model protein (fig 5.3). A possible reason 
for this fast AGE formation may be that the fructose-derived aldehydic AP (F-AP 
1) is particularly reactive and participates in post-Amadori reactions faster than 
those derived from glucose. D icarbonyl com pounds such as 3- 
deoxyglucosones (3-DG) derived from AP have been shown to induce both 
crosslinking and fluorophore formation of proteins in vitro (17, 18). Frudated 
proteins can form twice as much 3-DG as those that have been glucated (155), 
and furthermore fructose is known to form 3-DG directly at high temperatures 
(159) and it has been suggested that this may occur even under physiological 
conditions (155).
A higher proportion of fructose (0.7%) exists in the acyclic form compared to 
glucose (0.002%) and so fructose would be expected to form SB 350 times 
faster than glucose (10). Aldoses are approximately 50 times more reactive 
than ketoses, and so taking both factors into account, fructose would be 
expected to react 7.5 times faster than glucose. Indeed this is consistent with 
the in vitro studies of Bunn et al using radiolabelled sugars (11). Assuming that 
the rate of Amadori rearrangement is approximately the same for glucose and 
fructose-derived AP (although there is no information on this), then fructose- 
derived AP would be expected to form faster than those from glucose. 
However, this is contrary to the results in table 5.1. There are two possible
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explanations for this and it is likely that both are responsible for the apparent 
low levels of AP formed by fructated proteins. First since fructose-derived AP 
are rapidly converted to AGE, there is little buildup of these AP and this may 
account for their lower levels. The second reason may be that most assays are 
designed to detect the glucose-derived AP which is a ketone where the 
carbonyl group is on C-2 and is attached to protein via C-1. In contrast the 
fructose-derived aldehydic isomer (F-AP 1) is not expected to liberate HCHO 
after periodate oxidation (ref (99), see fig 5.6) nor is it expected to cyclize to 
form HMF and so may not be detected by either periodate or TBA assays. In 
addition, aldehydic AP's do not readily dehydrogenate (160) and so may not 
react with redox dyes such as NBT in the serum fructosamine assay. 
Furthermore, the conformation of this aldehydic AP lacks the cis diols needed 
for strong adsorption in the phenylboronate affinity chromatography method 
and hence a high percentage glycation reading. This could be because sugars 
may adopt a fructose-1 ike conformation in the glucose-AP (ie with a furanose 
ring as shown in the penultimate cyclic structure of fig 1.1), or a pyranosyl 
structure in the fructose-AP (as shown in the first cyclic structure of fig 1.1 but 
with C-1 substituted by -NHR). Fructose is well known to bind more strongly to 
phenylboronate resins than glucose does (161, 162). The ketone isomer with 
protein attached to 0-2 (F-AP 2) liberates HCHO upon periodate oxidation (fig 
5.6) but is unlikely to cyclize and form HMF, which may account for the higher 
fructation values obtained with the periodate than TBA assay. The 15% of 
fructose-derived AP identical to that from glucose probably accounts for the 
small positive reactions in the TBA and serum fructosamine assay.
From table 5.1, it can be seen that the major assays used to quantify glycation 
may underestimate fructation. However, it is clear from the fluorescence and
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crosslinking studies that fructose-induced changes to protein structure occur 
much faster than those induced by glucose. Evidence for in vivo fructation has 
been obtained only by charge based glycation assays possible with Hb (104), 
which would detect all the fructose-derived AP. Charge based separations 
depend on a drop in pK when amino groups are converted to SB or to AP, and 
this occurs for all AP during fructation. In subjects monitored only by the 
phenylboronate or serum fructosamine assays on serum albumin, any in vivo 
fructation would be greatly underestimated. Therefore dietary fructose could be 
causing structural damage that at present goes undetected. This could be 
relevant clinically, since diabetics can convert glucose to fructose via the 
sorbitol pathway and dietary fructose is a permitted sweetener for diabetics and 
a major component of the non-diabetic diet (eg combined with equimolar 
quantities of glucose in sucrose).
The DNPH assay was first used by Fields and Dixons to detect protein bound 
carbonyl groups (145). Studies by Ghiggeri et al have shown that with albumin 
a small percentage of ketoamine groups (~ 15%) generate colour as the 
phenylhydrazone, and borohydride reduction prior to assay results in no colour 
yield (157). Any SB, free sugar or 3-DG will result in the formation of 
hydrazones of low molecular weight (157), but extensive dialysis prior to assay 
should exclude any interference by these. It is important to stress that the 
DNPH assay should detect both aldehydic and ketonic carbonyl groups and 
would be expected to detect all fructose-derived AP. If a higher proportion of 
fructose-derived AP exist in the acyclic form (although there is no information 
on this) this may account for the higher levels of DNPH derivative produced by 
fructated compared to the glucated BSA. Furthermore carbonyl groups from 
AGE may also be detected and indeed the fluorescent-AGE pyrraline
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possesses a free carbonyl group and so too may others. This possibility 
becomes more plausible when comparing the increase in protein bound 
carbonyl groups (fig 5.5) for glucated and fructated BSA with their 
corresponding fluorescence changes (fig 5.2). In either case, the DNPH 
reaction provides a colorimetric assay that gives a truer measure of fructose- 
induced changes to protein structure than any of the other assays.
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Fig 5.6: Periodate oxidation of fructose-AP (adapted from ref (99).
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CHAPTER 6
Effect of Phosphate, pH and Calcium on AGE 
Formation
6.1: Introduction
Glycation has been shown to increase with period of incubation, concentration 
of sugar, and temperature (41). The extent of glycation can also be affected by 
the pH and concentration of phosphate.
Studies on the effects of pH and phosphate concentrations have looked at 
changes in AP formation and not post-Amadori products. When the pH is 
increased from 4.5 to 9.0, the extent of glycation increases (41). At a higher pH, 
a smaller proportion of the e-amino groups on lysine residues will be charged 
(ie less dissociation) and hence greater reactivity. Furthermore, a rise in pH 
can affect the percentage sugar in acyclic form ie as pH of glucose solution is 
increased from 6.5 to 7.5, the percentage sugar in the acyclic form increases 
from 0.012% to 0.04% (163). Phosphate has been shown to increase extent of 
AP formation by catalysing the Amadori rearrangement (164), and has no effect 
on the extent of SB formation. Phosphate could also increase reactivity of 
sugar since it increases the proportion of sugar in the acyclic form (165). 
Normal plasma levels of phosphate are between 1.6 to 2.3mM.
Mineral ions such as FeS0 4 , CUSO4 and CaCl2 in browning reactions have 
been studied by food chemists at elevated temperatures, however, their effects 
are controversial. For eg CaCig has been reported to reduce browning by 
Smith and Cline (166) and Yu et ai (167) whereas Fry and Stegink reported an 
increase in this reaction (168). More recent work by Labuza has suggested that 
electrolytes have no effect on the browning reaction (169). Calcium ions have
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been reported to shift equilibrium in favour of the a-anomer, but their effect on 
proportion of sugar in acyclic form is not known (170). Plasma levels of calcium 
ions are about 2.5mM and during hypercalcaemia can rise to 5mM. 
Approximately 0.9mM calcium is bound to albumin whereas 1.6mM exists as 
free ionised calcium.
In this study the effect of phosphate, pH and calcium ions on the formation of 
glucose-derived fluorescent-AGE were studied. Almost all studies so far have 
investigated the effects of these factors on glucose-induced changes and since 
the mechanism for fructose-induced changes to protein structure are different, 
the effect of phosphate, pH and calcium ions on fructose-derived fluorescent- 
AGE were also investigated.
Eble et al (55) and McPherson et al (57) have reported increased crosslinking 
and fluorescence of glycated RNase upon reincubation after removal of sugar. 
This rise in AGE was attributed to decreased competition between Amadori 
carbonyl groups and sugar carbonyl groups for free amino groups from protein. 
This led to the suggestion that once glycated, a protein will participate in AGE 
formation even on return to normoglycaemia, explaining why certain diabetic 
complications progress even after strict glycaemic control (171). In contrast, 
Schleicher et al found no significant increase in fluorescence generation of 
glycated albumin upon reincubation after exhaustive removal of sugars. 
However, a small consumption of Amadori groups was noted (90). Similarly, 
Kato et al did not observe a significant rise in browning of ovalbumin upon 
reincubation after removal of unbound sugar (172). A study by Rucklidge et al 
have found no evidence for a reaction between fructosyllysine (glucose- 
derived AP) and free amino groups from lysine residues in the absence of free 
sugar (173).
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In this chapter, glucated and fructated BSA were reincubated in the absence of 
sugars and the formation of fluorescent-AGE monitored. To examine whether 
the effect of phosphate, pH and calcium ions on fluorescence changes are due 
to effects on post- as opposed to pre-Amadori reactions, the effect of these 
factors on fluorescent-AGE in absence of sugars were also investigated. Since 
many of the crosslinked-AGE are non-fluorescent, the effect of phosphate, 
calcium ions and pH on formation of crosslinked-AGE upon reincubation of 
glycated lysozyme, after removal of sugars, was also investigated.
6.2: Aims
1: To investigate the effect of phosphate, calcium ions and pH on
generation of fluorescent-AGE formed by BSA incubated in the presence 
of glucose or fructose.
2: To investigate the effect of phosphate, calcium ions and pH on post-
Amadori reactions responsible for fluorescent-AGE by incubating the 
isolated AP ie glucated or fructated BSA in absence of sugars.
3: To investigate the effect of phosphate, calcium ions and pH on post-
Amadori reactions responsible for crosslinked-AGE by incubating 
glucated or fructated lysozyme in the absence of sugars.
6.3: Experimental Protocol 
In Vitro Glycation: Fast glycation involved incubating BSA (fraction V) at 
lOmg/ml in 0.5M glucose or fructose at 37oC in either (a) 0.05M HEPES/3mM 
sodium azide, pH 7.4 +/- 2.5-1 OmM calcium chloride or (b) in 0.0 5M sodium 
phosphate buffer/3mM sodium azide, pH 5.7-8.0, or (c) 0.05-0.3M sodium 
phosphate/3mM sodium azide, pH 7.4 for upto 21 days (section 2.1).
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Glycated protein for reincubation was prepared by incubating BSA (12mg/ml) 
in 0.5M glucose or fructose for 16 and 11 days respectively in 0.05M sodium 
phiosphate/3mM sodium azide buffer, pH 7.4 at 37^0. Lysozyme was also 
glycated by glucose and fructose for 6 and 4 days respectively under the above 
conditions. All proteins were dialysed exhaustively against water to remove 
unbound sugars (section 2.2). BSA (6mg/ml) was incubated at 37°C alone 
and in 0.5M glucose for 16 days and in 0.5M fructose for 11 days in 0.05M 
sodium phosphate buffer/3mM sodium azide, pH 7.4. The fluorescence was 
determined before and after 4 days of dialysis with 8 changes.
Reincubation of Glycated Proteins: Glycated proteins were reincubated 
for the stated periods of time at 37°C in; (a) calcium (2.5-1 OmM) in HERBS 
buffer, pH 7.4 (b) in 0.05M sodium phosphate buffer of varying pH (5.7-8.0) or 
(c) sodium phosphate buffer of varying concentration (0-0.2M). In all cases the 
buffers contained 3mM sodium azide to prevent bacterial growth. Samples 
were dialysed against distilled water (section 2.2) and stored frozen.
Protein Concentration: This was determined using the Pierce protein assay 
reagent (section 2.4.2).
Measurement of AGE: AGE were measured by their fluorescence changes 
(section 2.9.1) or crosslinking on SDS gels (section 2.9.2).
Statistical analysis was performed using the Students t test.
6.4: Results
Effect of phosphate: Phosphate (0-0.2M) has no effect on fluorescence of 
BSA incubated in the absence of sugars (fig 6.1). However, a dose dependent 
effect of phosphate is demonstrable on fluorescence of BSA incubated in 
glucose (fig 6.2) or fructose (fig 6.3), and is more pronounced for the latter. 
Phosphate promotes a rapid increase in fructose-induced fluorescence
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particularly during the first 5 days of incubation but then slows down. In 
contrast, the rise in fluorescence of BSA incubated in glucose is gradual but 
linear throughout the period of incubation. This would be expected since the 
absolute extent of glycation here is still well below the saturation levels 
approached by fructose.
To study the effect of phosphate on post-Amadori reactions only, glycated 
protein prepared in vitro was dialysed to remove unbound sugar and SB and 
then reincubated for a certain period of time. On reincubation of dialysed 
glucated BSA in a non-phosphate (HEPES) buffer (fig 6.4) in the absence of 
sugar, no further increase in fluorescence is detectable. However, some further 
fluorescence is generated upon reincubation in a phosphate buffer and this 
effect is higher with increasing concentrations of phosphate (fig 6.4). With 
fructated BSA, virtually no further rise in fluorescence is detectable in the 
absence of sugar under these conditions and phosphate appears to have no 
effect on post-Amadori reactions responsible for fluorescence generation (fig 
6.5).
Lysc ■ ,e was chosen as a model protein to study crosslinked-AGE since it 
readily polymerises. Non glycated lysozyme, glucated and fructated lysozyme 
showed no increase in crosslinking upon reincubation in the absence of 
sugars for 9 days and phosphate appeared to have a small inhibitory effect on 
crosslinking of both glucated and fructated lysozyme ( fig 6.6 and table 6.1).
Effect of pH: An increase in pH (from 5.7 to 8.0) has no effect on the 
fluorescence of BSA incubated alone (fig 6.7), but does increase the 
fluorescence of BSA incubated in glucose (fig 6.8) or fructose (fig 6.9). The 
fluorescence of glucated BSA is approximately 8 times higher at pH 8 
compared to pH 5.7 after 21 days of incubation (fig 6.8). With fructated BSA the
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increase reaches saturation with maximum values being attained after 7 days 
of incubation (fig 6.9). As with the phosphate studies, reincubated glucated 
BSA generated a small increase in fluorescence which increased with pH (fig 
6.10) but no change in fluorescence of fructated BSA was detectable even at 
high pH (fig 6.11). As the pH was increased from 5.7 to 8.0, the crosslinking of 
glucated but not fructated lysozyme increased twofold after 9 days of 
reincubation in the absence of sugar (fig 6.12 and table 6.2).
Effect of calcium: Calcium ions have no effect on fluorescence of BSA 
incubated alone (fig 6.13), but do increase the fluorescence of BSA Incubated 
in glucose (fig 6.14) or fructose (fig 6.15) although this increase is not as 
dramatic as with the phosphate and pH studies. Glucated BSA (fig 6.16) and 
fructated BSA (fig 6.17) reincubated in the absence of sugar in HEPES buffer 
shows no increase in fluorescence and calcium ions have no effect in either 
case. Similarly, calcium ions have no effect on the crosslinking of lysozyme, 
glucated and fructated lysozyme reincubated in the absence of sugars for upto 
9 days (fig 6.18 and table 6.3).
These experiments were repeated two times (n=2) and the most representative 
results are shown.
Fig 6.19 shows the fluorescence of BSA and glycated BSA before and after 
dialysis. There is a significant rise in fluorescence of both glucated (p< 0.05) 
and fructated BSA (p< 0.001).
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Fig 6.1 : Effect of phosphate on fluoresence of BSA (lOmg/ml) incubated in the
absence of sugar
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Fig 6.2: Effect of phosphate on fluorescence of BSA (10mg/ml) incubated in 0.5M
glucose
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Fig 6.3: Effect of phosphate on fluorescence of BSA (10mg/ml) incubated in 0.5M
fructose
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Fig 6.4: Effect of phosphate on fluorescence of glucated BSA reincubated in the
absence of sugar
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Fig 6.5: Effect of phosphate on fluorescence of fructated BSA reincubated in the
absence of sugar
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Fig 6.6: SDS-PAGE of lysozyme (lanes B and C), glucated lysozyme (lanes E 
and F) and fructated lysozyme (lanes H and I) incubated in 0.05 and 0.2M 
phosphate respectively for 9 days in the absence of sugar. Also shown is 
lysozyme (lane A), glucated lysozyme (lane D) and fructated lysozyme (lane G) 
before reincubation.
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Protein sample Time (days) Phosphate (M) % Oligomer
Lysozyme 0 0.05 0
Lysozyme 9 0.05 0
Lysozyme 9 0.20 0
Glue lysozyme 0 0.05 6.4
Glue lysozyme 9 0.05 6.5
Glue lysozyme 9 0.20 5.7
F rue lysozyme 0 0.05 28.3
Frue lysozyme 9 0.05 28.0
Frue lysozyme 9 0.20 24.7
Table 6.1 : Effect of phosphate on crosslinking of lysozyme, glucated lysozyme 
and fructated lysozyme re incubated in the absence of sugar
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Fig 6.7; Effect of pH on fluorescence of BSA (lOmg/ml) incubated in the absence of
sugar
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Fig 6.8: Effect of pH on fluorescence of BSA (lOmg/ml) incubated in 0.5M glucose
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Fig 6.9: Effect of pH on fluorescence of BSA (lOmg/m!) incubated in 0.5M fructose
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Fig 6.10: Effect of pH on fluorescence of glucated BSA reincubated in the absence
of sugar
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Fig 6.11 : Effect of pH on fluorescence of fructated BSA reincubated in the absence
of sugar
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Fig 6.12: SDS-PAGE of lysozyme (lanes B and 0), glucated lysozyme (lanes E 
and F) and fructated lysozyme (lanes H and I) incubated in buffer of pH 5.7 and 
8.0 respectively for 9 days in the absence of sugar. Also shown is lysozyme 
(lane A), glucated lysozyme (lane D) and fructated lysozyme (lane G) before 
reincubation.
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Protein sample Time (days) pH % Oligomer
Lysozyme 0 5.7 0
Lysozyme 9 5.7 0
Lysozyme 9 8.0 0.2
Glue lysozyme 0 5.7 3.6
Glue lysozyme 9 5.7 3.2
Glue lysozyme 9 8.0 6.4
Frue lysozyme 0 5.7 28.0
Frue lysozyme 9 5.7 28.5
Frue lysozyme 9 8.0 25.6
Table 6.2: Effect of pH on crosslinking of lysozyme, glucated lysozyme and 
fructated lysozyme reincubated in the absence of sugar
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Fig 6.13: Effect of calcium on fluorescence of BSA (lOmg/ml) incubated in the
absence of sugar
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Fig 6.14: Effect of calcium on fluorescence of BSA (lOmg/ml) incubated in 0.5M
glucose
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Fig 6.15: Effect of calcium on fluorescence of BSA (lOmg/ml) incubated in 0.5M
fructose
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Fig 6.16: Effect of calcium on fluorescence of glucated BSA reincubated in the
absence of sugar
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Fig 6.17: Effect of calcium on fluorescence of fructated BSA reincubated in the
absence of sugar
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Fig 6.18: SDS-PAGE of lysozyme (lanes Band C), glucated lysozyme (lanes E 
and F) and fructated lysozyme (lanes H and I) incubated in 0 and 5mM calcium 
respectively for 9 days in the absence of sugar. Also shown is lysozyme (lane 
A), glucated lysozyme (lane D) and fructated lysozyme (lane G) before 
reincubation.
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Protein sample Time (days) Calcium (mM) % Oligomer
Lysozyme 0 0 0
Lysozyme 9 0 0
Lysozyme 9 5 0
Glue lysozyme 0 0 4.3
Glue lysozyme 9 0 3.4
Glue lysozyme 9 5 4.1
Frue lysozyme 0 0 24.3
Frue lysozyme 9 0 24.0
Frue lysozyme 9 5 26.4
Table 6.3: Effect of calcium on crosslinking of lysozyme, glucated lysozyme and 
fructated lysozyme reincubated in the absence of sugar
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Fig 6.19: Fluorescence of BSA incubated alone (Cont 1), in 0.5M glucose (Gluc 
1) or fructose (Fruc 1) before dialysis and after 4 days of dialysis (Cont 2, Gluc 
2 and Fruc 2). Results are expressed as mean +/- SD for duplicate 
experiments.
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6.5: Discussion
From my results, it is clear that phosphate (fig 6.1), pH (fig 6.7) and calcium (fig 
6.13) have no effect on fluorescence of BSA alone and any increase is 
mediated via glycation. Other workers have shown that phosphate increases 
glucation of RNase by catalysing the Amadori rearrangement and this has 
been said to account for the higher glycation values obtained during in vitro 
glycation of proteins in phosphate buffers (164). The increased glycation may 
be in part due to greater reactivity of the sugar since phosphate also increases 
the proportion of sugar in the acyclic form (165). Here an increase in 
fluorescence of glucated and fructated BSA with phosphate has been 
demonstrated (figs 6.2 and 6.3 respectively). This increase is probably due to 
increased AP formation of BSA in phosphate and to increased secondary 
glycation (discussed in next chapter). However, the possibilty that phosphate 
may be catalysing formation of intermediates in the Maillard reaction cannot be 
excluded. A small phosphate-catalysed increase in fluorescence is detectable 
for glucated BSA reincubated in the absence of sugars (fig 6.4) but not for 
fructated BSA (fig 6.5). In the case of glucated BSA, phosphate was required 
for the increase in fluorescence since incubation in a non phosphate buffer 
produced no change in fluorescence at pH 7.4 (fig 6.16). This compares with 
earlier work by McPherson et al who reported a significant rise in fluorescence 
of both glucated and fructated RNase upon reincubation in the absence of 
sugars in a phosphate buffer (57). However, Schleicher et al (90) and Kato et 
al (172) could not detect any appreciable rise in fluorescence upon 
reincubation of glucated albumin. Eble et al reported increased crosslinking of 
glucated RNase upon removal of sugars which was attributed to decreased 
competition between carbonyl groups from AP and glucose for free amino 
groups on protein (55). Using glycated lysozyme, no such increase in
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crosslinking was demonstrable after removal of free sugar in this study (table 
6.1). It is noteworthy that previous studies showing increases in crosslinking of 
glucated proteins upon removal of free sugar used RNase which was 
reincubated in phosphate buffer (55, 57). It may well be possible that only 
certain proteins are susceptible to crosslinking upon removal of unbound 
sugar.
Fluorescence of BSA incubated in glucose (fig 6.8) or fructose (fig 6.9 ) also 
increased with pH but only a small rise was noted for glucated BSA incubated 
in the absence of sugars (fig 6.10) whereas no change was detectable for 
fructated BSA (fig 6.11). An increase in crosslinking of glucated lysozyme is 
detectable upon reincubation in the absence of sugar and the reasons for this 
are not clear (table 6.2). Increased glycation at higher pH has been reported by 
several workers, and is due to a higher proportion of unprotonated amino 
groups and greater reactivity of sugar since a higher proportion exists in the 
acyclic form with increased pH. Both of these effects will increase AP formation 
which in turn increases AGE formation. However, the results for glucated BSA 
reincubated in phosphate buffer of increasing pH in the absence of sugar do 
suggest the possibility that conversion of AP to fluorophores may occur faster at 
a higher pH.
Calcium increases fluorescence of BSA incubated in glucose (fig 6.14) or 
fructose (fig 6.15) even at physiological concentrations, although the rise is not 
as marked as that with phosphate or pH. However it is not known whether this 
rise is statistically significant. Calcium has no effect on fluorescence of glycated 
BSA (figs 6.16 and 6.17) or crosslinking of glycated lysozyme (table 6.3) 
reincubated in the absence of sugar. The mechanism by which calcium may 
induce a rise in fluorescence of BSA incubated in sugars is not clear but it is
Page 144
possible that binding of calcium ions to albumin may produce conformational 
changes in the protein increasing its susceptib ility to glycation and 
fluorescence formation.
These studies suggest that free sugars are required for fluorescence and 
crosslinking of proteins and conflict with the findings of Eble et al (55) and 
McPherson et al (57) who have suggested that once a protein is glycated it will 
participate in AGE formation on return to normoglycaemia. However this in vitro 
study suggests that this may not be the case and may account for the 
improvement of certain diabetic complications upon strict metabolic control of 
glucose.
During dialysis of both glucated and fructated BSA, a rise in fluorescence 
occurs (fig 6.19) which is greater with fructated compared to glucated BSA. 
This suggests that the conversion of fructose-derived AP to AGE may reach 
saturation during dialysis hence the lack of fluorescence generation upon 
reincubation. Furthermore crosslinking has been reported to precede 
fluorophore formation and may have gone to completion during dialysis (over a 
period of 4 days). This may explain why glucated BSA still exhibits an increase 
in fluorescence but not crosslinking upon reincubation. A major limitation of the 
dialysis procedure is the time period required for adequate removal of 
unbound sugar. Over this period the Maillard reaction continues to proceed 
and important changes may have been masked thus a more rapid method 
would have been more appropriate.
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CHAPTER 7
Secondary Glycation of Proteins
7.1 : Introduction
During in vitro glycation of proteins, fructose induces fluorescence 
considerably faster than glucose and this is believed to be due to two major 
reasons; (i) greater reactivity of fructose compared to glucose since a higher 
proportion exists in the acyclic form and (ii) faster conversion of fructose- 
derived AP (in particular those that are aldehydic in nature) to fluorophores 
probably due to their greater reactivity. Some workers have reported that 
removal of free sugar after glycation results in a faster increase in fluorescence 
(55, 57), however, our results in the previous chapter could not confirm these 
findings. It therefore seems that free sugar is actually required for fluorescence 
generation, particularly in the case of fructose.
The work in this chapter was carried out at the New York Medical College 
under the supervision of Dr Gerardo Suarez and evidence is presented for a 
reaction between free sugars and Amadori groups (named secondary 
glycation) which is responsible for generation of fluorescent products. In order 
to study the reaction between free sugars and AP, it was necessary to block 
any free amino groups in the glycated protein to prevent reinitiation of 
glycation. This process named reductive méthylation can be outlined as;
Protein— N H i -------------HCHO----------------^  Protein— N H — C H 3
NaCNBHj
Free amino groups from protein were blocked by methyl groups after treatment 
with HCHO and sodium cyanoborohydride (142).
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This secondary glycation is particularly pronounced for fructose and may 
account for the higher fluorescence of fructated proteins. It also provides an 
explanation for the lack of fluorescence generated by glycated proteins upon 
reincubation in the absence of sugars.
7.2: Aims
1: To investigate whether free glucose can induce fluorescence of BSA by
reaction with the AP .
2: To investigate whether free fructose can also do the same and how this
compares with glucose.
3: To investigate how the above changes in fluorescence relate to the
changes in free amino and Amadori groups.
7.3: Experim ental Protocol 
In Vitro Glycation: BSA (fatty acid free) at a concentration of 6mg/ml was 
incubated at 370C in 0.5M glucose for 16 days in 0.05M sodium phosphate 
buffer, pH 7.0 under sterile conditions (section 2.1). The glucated BSA was 
dialysed exhaustively to remove free sugar (section 2.2) and stored frozen. 
Reductive Méthylation of Glucated BSA: The dialysed glucated BSA 
was reductively methylated to block free amino groups (section 2.5). 
Reincubation of RM Glucated BSA: The reductively methylated glycated 
BSA was reincubated at 370C in 0.1 M glucose, fructose or in the absence of 
sugar in 0.05M sodium phosphate buffer, pH 7.0 for upto 25 days and stored 
frozen. Samples were dialysed (section 2.2) and stored frozen prior to any 
assays.
Protein Concentration: Protein was assayed according to the method of 
Lowry (section 2.4.1).
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TNBS Assay: Free amino groups were assayed according to the TNBS 
assay (section 2.7).
Measurement of AP: The levels of AP were measured using the periodate 
assay according to the Gallop procedure (section 2.8.1).
Measurement of AGE: Samples were digested with proteinase K (section 
2.6) before fluorescence measurements (section 2.9.1). These assays were 
also performed on samples prior to reincubation.
7.4: Results
Reductively methylated (RM) glucated BSA in the absence of sugars did not 
show an increase in fluorescence upon reincubation (fig 7.1). However, 
fluorescence increased in the presence of glucose and was higher with 
fructose (fig 7.1), clearly suggesting that free sugars are required for 
fluorescence of glycated proteins, and that fructose is more reactive in this 
respect. Prior to reincubation, the glucated BSA had 2.5 amino groups per 
mole and released 5.5 moles of HCHO per mole of protein. To show that this 
increase in fluorescence was not due to reinitiation of glycation, free amino 
groups were monitored over the reincubation period (fig 7.2), and no 
consumption of these groups was detectable. If Amadori products are required 
for formation of fluorophores, then consumption of these groups should occur 
with increase in fluorescence, and for this reason, they too were monitored. 
The moles of AP per mole of protein declined with period of incubation for all 
samples (fig 7.3). The decline in AP levels for RM-glucated BSA reincubated 
alone was only seen in this particular experiment and could not be reproduced. 
In a separate experiment, RM-glucated BSA reincubated alone shows no 
decline in AP levels whereas a decline is seen in the presence of glucose or 
fructose (fig 7.4).
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Fig 7.1 : Fluorescence of RM-glucated BSA reincubated alone or in 0.1M sugar
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Fig 7.3: Apparent AP levels in RM-glucated BSA reincubated alone or in 0.1 M sugar
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7.5: Discussion
Glycated BSA was methylated to prevent further glycation occurring at the free 
amino groups. Sodium borohydride could have been used instead of 
cyanoborohydride since it is a stronger reducing agent. However, use of 
borohydride for reductive méthylation may cause reduction of Amadori groups 
as well as peptide cleavage which will generate new free amino groups (142). 
Due to the high number of free amino groups within BSA, the process of 
reductive méthylation had to be repeated (5-6 times) to achieve acceptable 
blocking of free amino groups. Complete blocking was not possible since even 
with cyanoborohydride, a small amount of fragmentation does occur. The RM- 
glucated BSA was then reincubated with sugars to study interaction between 
free sugar and the AP. Fluorescence measurements of RM-glucated BSA were 
made on proteinase K digests. This digestion was necessary because 
conformational changes induced by méthylation may cause fluorescent groups 
within BSA to come into close proximity with quenching groups in other 
domains of protein causing a decline in fluorescence measured. Indeed, this 
was the case and was remedied by digestion of the protein. The RM-glucated 
BSA reincubated alone showed no increase in fluorescence, whereas an 
increase is seen in the presence of glucose or fructose (fig 7.1). This 
demonstrates that sugars are required for fluorescence formation which is 
considerably greater with fructose. This increase in fluorescence is not due to 
reinitiation of glycation since levels of free amino groups remain unchanged 
(fig 7.2). Furthermore, reinitiation of glycation should result in generation of AP 
which is not the case since a decline in AP is observed (fig 7.3). This 
consumption of AP may be accounted by their reaction with free sugars to 
generate fluorophores assuming that the sugar-AP adducts do not release 
HCHO after periodate oxidation. This reaction (named secondary glycation) is
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faster with fructose leading to a higher generation of fluorescence and 
consumption of AP presumably because a greater proportion exists in the 
acyclic form compared to glucose. The consumption of AP in RM glucated BSA 
reincubated in the absence of sugar was unexpected, and the reason for this is 
not known. However it is worth pointing out that these experiments were 
repeated three times and in other experiments the AP levels in RM glucated 
BSA reincubated alone remained constant (fig 7.4). These results provide 
indirect evidence for the reaction of free sugars with AP producing fluorescent 
products. Dr G.Suarez has proposed a hypothetical pathway by which this 
reaction may occur (fig 7.5);
(i) the free carbonyl group of fructose adds to the secondary amino group on 
AP via a nucleophilic addition reaction.
(ii) the C-1 on added fructose could then combine with the C =0 group of AP 
by aldol condensation so that the ring closes.
(ill) double dehydration from this ring structure could then generate a pyrrole.
This pyrrolic structure may go on to form a fluorophore or may be fluorescent 
itself. Furthermore, this product has a carbonyl group and could participate in 
crosslink formation although this has not been investigated in this study. 
Pyrrolic structures have been demonstrated as intermediates in the Maillard 
reaction (17) and have been detected in vivo bound to collagen using Ehrlichs 
reagent (174). This secondary glycation may increase the fluorescence of 
previously glycated protein in vivo and may account for the lack of fluorescence 
generated by glycated proteins reincubated in the absence of sugars. 
Furthermore, it also accounts in part, for the high fluorescence during fructation 
compared to glucation.
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CHAPTER 8
Inhibitors of Post-Amadori Reactions
8.1: Introduction
At present there is considerable interest in compounds which can inhibit AP 
formation or post-Amadori reactions because of their possible therapeutic 
potential in preventing the secondary complications of diabetes. Furthermore 
such compounds are of interest in food chemistry where they could be used to 
reduce or prevent undesirable changes in foods containing protein and sugars, 
particularly during storage. A number of compounds have been shown to 
inhibit glycation or AGE formation either in vitro or in vivo. The mechanisms by 
which these compounds act can be divided into three types;
(i) blocking of free amino groups from proteins preventing them from being 
glycated or participating in AGE formation eg acetylsalicylic acid (127).
(ii) blocking of free carbonyl groups from sugars, AP and reactive 
intermediates such as 3-DG eg aminoguanidine (122) and penicillamine 
(57).
(iii) antioxidants and free radical scavengers may be used to inhibit AGE 
derived by autoxidative glycation eg vitamin E (134) and sorbitol (33).
Aminoguanidine has received the most attention and has been shown to 
reduce glycation (121) as well as fluorescent and crosslinked AGE formation in 
vitro (119). Comparative studies between am inoguanidine, pyridoxal 
phosphate and ascorbate have shown that am inoguanidine is the most 
effective at reducing in vitro glucation of serum albumin (175). In this work, 
equimolar concentrations of aminoguanidine and three other inhibitors, two of
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which act by different mechanisms have been used to determine which is the 
most effective at reducing fluorescence and crosslinking of lysozyme. Since the 
mechanism of fructose-derived fluorescence and crosslinking of proteins may 
be different from that of glucose, the inhibitory effect of these compounds on 
fructose-derived changes to protein structure were also investigated. The three 
proposed inhibitors apart from aminoguanidine used in this study include 
acetylsalicylic acid, L-lysine and N-acetyl-L-cysteine.
Acétylation of proteins by acetylsalicylic acid has been reported to occur by two 
orders of magnitude faster than glycation (176) which is probably why this 
compound is an effective antiglycation agent. Unlike the other compounds 
acetylsalicylic acid is used clinically as an analgesic and patients with 
rheumatoid arthritis may have plasma levels of upto 200uM (177). I used this 
concentration of acetylsalicylic acid to determine whether it would be effective 
at reducing fluorescence of albumin exposed to levels of glucose found in 
diabetics.
L-lysine is a naturally occurring amino acid and its mechanism of inhibition 
should be similar to aminoguanidine. Previous studies by Sensi et al have 
demonstrated inhibition of glycation by D-lysine (178) and to my knowledge 
this is the first study to investigate the effect of L-lysine on sugar-derived AGE in 
proteins. If naturally occurring substances like lysine can reduce AGE 
formation, then it may be more appropriate to use these in vivo since they are 
likely to be less toxic than aminoguanidine. A problem with using L-lysine in 
vivo is that this amino acid is incorporated into proteins. This is not the case 
with D-lysine, but in vivo the D isomer can be readily converted to the L isomer 
(167).
Free radicals derived by sugar autoxidation can cause crosslinking and 
fluorescence of proteins and these changes are indistinguishable from those
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that arise via the Amadori route. N-acetyl-L-cysteine is a free radical scavenger 
and should inhibit fluorescence and crosslinking of proteins by free radicals 
generated during sugar autoxidation. This compound was used to see whether 
free radicals produced during sugar autoxidation are of significance in 
producing the crosslinking and fluorescence changes.
The compound ortho-phenylenediamine can react with dicarbonyl compounds 
and has been used to isolate deoxyglucosones (179). In this study the effect of 
ortho-phenylenediamine on glucose and fructose-derived fluorescence and 
glycation of BSA was investigated. The effect of ortho-phenylenediamine on 
glucose and fructose-induced crosslinking of lysozyme was also investigated.
W hether any of the above compounds are of use in preventing diabetic 
complications remains to be seen, however, these compounds are of use as 
tools for studying mechanisms of glycation and AGE formation.
Aspects of this work, in particular the effect of phenylenediamine on BSA 
glycation and fluorescence was carried out at the New York Medical College, 
U.S.A. under the supervision of Dr Gerardo Suarez.
8.2; Aims
1 : To compare the effects of equimolar concentrations of proposed inhibitors
which act by different mechanisms to determine which type is the most 
effective at reducing glucose and fructose-derived fluorescence and 
crosslinking of lysozyme.
2: To investigate whether doses of acetylsalicylic acid achieved in vivo can
protect against fluorescent-AGE formed on proteins exposed to levels of 
glucose found in diabetes.
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3: To investigate the effect of phenylenediamine on glucose and fructose-
derived glycation and fluorescence of BSA.
4: To investigate the effect of phenylenediamine on glucose and fructose-
derived crosslinking of lysozyme.
8.3: Experimental Protocol
In Vitro Glycation: Lysozyme (10mg/ml) and BSA fatty acid free (6mg/ml) 
were incubated in 0.1 M sugar (+/- 0.25-2.5mM of the stated inhibitor) for upto 7 
days in 0.1 or 0.2M sodium phosphate/SmM sodium azide buffer, pH 7.4 at 
37°C (section 2.1). MSA (40mg/ml) was incubated in 20mM glucose +/- 200uM 
acetylsalicylic acid in 0.05M sodium phosphate buffer/6mM sodium azide 
under the above conditions for upto 45 days. Samples were dialyzed to 
remove free sugar and inhibitors (section 2.2).
Protein Concentration: The protein was assayed using the Pierce BCA 
protein assay reagent (section 2.4.2).
Measurement of AP: The AP levels were measured using the periodate 
assay according to the Gallop procedure (section 2.8.1).
Measurement of AGE: The AGE were detected by their fluorescence 
(section 2.9.1) or crosslinking (section 2.9.2).
Statistical analysis was performed using the Students t test.
8.4: Results
Fig 8.1 shows the effect of acetylsalicylic acid on sugar-derived fluorescence of 
lysozyme. The fluorescence of lysozyme increases by about 50% when 
incubated with glucose and almost 8 fold in the fructose incubation. 
Fluorescence of lysozyme incubated in acetylsalicylic acid is much greater 
than in incubations of lysozyme with sugars alone. This acétylation of lysozyme
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will therefore mask any inhibitory effect on sugar-derived fluorescence. 
Preliminary results show that lower concentrations of acetylsalicylic acid 
(200uM) inhibit glucose-derived fluorescence of HSA by 15% after 45 days of 
incubation. HSA incubated in acetylsalicylic acid alone appears to show an 
increase in fluorescence (fig 8.2). It is not known whether these changes are 
significant and this experiment needs to be repeated several times for 
statistically viable data.
Am inoguanidine reduces both glucose (p<0.001) and fructose-derived 
(p<0.001) fluorescence of lysozyme (fig 8.3). Glucose-derived fluorescence of 
lysozyme is reduced to that generated by non-glycated lysozyme after 
incubation with aminoguanidine whereas fructose-derived fluorescence is 
inhibited by over 70%.
L-lysine causes a significant reduction of both glucose (p<0.01) and fructose- 
derived fluorescence of lysozyme (p<0.001) (fig 8.4).
The free radical scavenger N-acetyl-L-cysteine decreases glucose-derived 
fluorescence of lysozyme (p<0.05) but not fructose-derived fluorescence (fig 
8.5).
When the effect of these compounds on crosslinking was examined, 
aminoguanidine proved to be the most effective in the order aminoguanidine > 
acetylsalicylic acid > L-lysine > N-acetyl-L-cysteine (figs 8.6 and 8.7 and table
8 .1).
Phenylenediamine was found to have no effect on AP formation of BSA as 
shown in table 8.2. However, there was significant reduction of both glucose 
and fructose-derived fluorescence of BSA (p<0.001). G lucose-derived 
fluorescence of BSA was reduced by 29% and 45% in incubations with 
0.25mM and 0.50mM phenylenediamine respectively (fig 8.8). For fructose- 
induced fluorescence, the corresponding reductions were 35% and 48% (fig
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8.9). An increase in fiuorescence of BSA incubated alone with 
phenylenediamine also occurs despite extensive dialysis to remove any 
unbound phenylenediamine (figs 8.8 and 8.9).
Phenylenediamine reduced crosslinking of both glucated and fructated 
lysozyme in a dose dependent manner (fig 8.10). The ability of 
phenylenediamine to inhibit crosslinking of fructated lysozyme appears to be 
greater than its abilty to inhibit crosslinking of glucated lysozyme (table 8.3).
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Fig 8.1 : Fluorescence of lysozyme (lOmg/ml) incubated for 7 days either alone 
(C), in 0.1 M glucose (G) or fructose (F). The effect of 2.5mM acetylsalicylic acid 
on fluorescence of lysozyme incubated alone (A), in 0.1 M glucose (G+A) or 
fructose (F+A) is also shown. Results are expressed as mean +/- S D (n=5).
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Fig 8.2: Fluorescence of HSA (40mg/mi) incubated either in the absence (C) or 
presence of 20mM glucose (G). The effect of 200uM acetylsalicylic acid on 
fluorescence of HSA incubated in the absence (A) or presence of 20mM 
glucose (G+A) is also shown.
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Fig 8.3: Fluorescence of lysozyme (10mg/ml) incubated for 7 days either alone 
(C), in 0.1 M glucose (G) or fructose (F). The effect of 2.5mM aminoguanidine on 
fluorescence of lysozyme incubated alone (AG), in 0.1 M glucose (G+AG) or 
fructose (F+AG) is also shown. Results are expressed as mean +/- SD (n=5).
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Fig 8.4: Fluorescence of lysozyme (10mg/ml) incubated for 7 days either alone 
(C), in 0.1 M glucose (G) or fructose (F). The effect of 2.5mM L-lysine on 
fluorescence of lysozyme incubated alone (LL), in 0.1 M glucose (G+LL) or 
fructose (F+LL) is also shown. Results are expressed as mean +/- SD (n=5).
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Fig 8.5: Fluorescence of lysozyme (lOmg/ml) incubated for 7 days either alone 
(C), in 0.1 M glucose (G) or fructose (F). The effect of 2.5mM N-acetyl-L-cysteine 
on fluorescence of lysozyme incubated alone (AC), in 0.1 M glucose (G+AC) or 
fructose (F+AC) is also shown. Results are expressed as mean +/- SD (n=5).
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Fig 8.6: SDS-PAGE of lysozyme (10mg/ml) incubated in the absence (lane A) 
or presence of 0.1 M glucose (lane B) or fructose (lane C) for 7 days. The effect 
of 2.5mM acetylsalicylic acid and aminoguanidine on lysozyme incubated in 
the absence (lanes D and G) or presence of 0.1 M glucose (lanes E and H) or 
fructose (lanes F and I) respectively are also shown.
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Fig 8.7: SDS-PAGE of lysozyme (lOmg/ml) incubated in the absence (lane A) 
or presence of 0.1 M glucose (lane B) or fructose (lane C) for 7 days. The effect 
of 2.5mM L-lysine and N-acetyl-L-cysteine on lysozyme incubated in the 
absence (lanes D and G) or presence of 0.1 M glucose (lanes E and H) or 
fructose (lanes F and I) respectively are also shown.
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Protein Sugar Inh ib ito r % Oligomer
Lysozyme None None 0
Lysozyme Glucose None 1.3
Lysozyme Fructose None 14.5
Lysozyme None ASA 0
Lysozyme Glucose ASA 0
Lysozyme Fructose ASA 7.4
Lysozyme None Aminoguanidine 0
Lysozyme Glucose Aminoguanidine 0
Lysozyme Fructose Aminoguanidine 2.3
Lysozyme None L-lysine 0
Lysozyme Glucose L-lysine 0.7
Lysozyme Fructose L-lysine 10.5
Lysozyme None NALC 0
Lysozyme Glucose NALC 1.0
Lysozyme Fructose NALC 18
Table 8.1: Effect of 2.5mM acetylsalicylic acid (ASA), aminoguanidine, L-lysine 
or N-acetyl-L-cysteine (NALC) on crosslinking of lysozyme (lOm g/m l) 
incubated for 7 days in the absence or presence of 0.1 M sugar in 0.1 M 
phosphate.
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Protein Sugar PD Moles AP/mol
BSA None None 0.33
BSA None 0.25mM 0.30
BSA None O.SOmM 0.34
BSA Glucose None 1.9S
BSA Glucose 0.25mM 1.9S
BSA Glucose O.SOmM 1.98
BSA Fructose None 0.S2
BSA Fructose 0.25mM 0.46
BSA Fructose O.SOmM 0.4S
Table 8.2: Effect of phenylenediamine (PD) on apparent AP levels in BSA 
(6mg/ml) incubated for 7 days in the absence or presence of 0.1 M sugar.
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Fig 8.8: Fluorescence of BSA (6mg/ml) incubated for 7 days either alone (C) or 
in 0.1 M glucose (G). The effect of phenylenediamine on fluorescence of BSA 
incubated either alone (PD 1, PD 2) or in 0.1 M glucose (G+PD 1, G+PD 2) is 
also shown where PD 1 is 0.25mM and PD 2 is O.SOmM phenylenediamine. 
Results are expressed as mean +/- SD of duplicate experiments.
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Fig 8.9: Fluorescence of BSA (6mg/ml) incubated for 7 days either alone (C) or 
in 0.1M fructose (F). The effect of phenylenediamine on fluorescence of BSA 
incubated alone (PD 1, PD 2) or in 0.1 M fructose (F+PD 1, F+PD 2) is also 
shown where PD 1 is 0.25mM and PD 2 is O.SOmM phenylenediamine. Results 
are expressed as mean +/- SD of duplicate experiments.
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Fig 8.10; SDS-PAGE of lysozyme (lOmg/ml) incubated for 7 days in (i) the 
absence of sugar with 0, 0.25 and 2.5mM phenylenediamine (lanes A, B and C 
respectively), (ii) 0.1 M glucose with 0, 0.25 and 2.5mM phenylenediamine 
(lanes D, E and F respectively) and (iii) 0.1 M fructose with 0, 0.25 and 2.5mM 
phenylenediamine (lanes G, H and I respectively).
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Protein Sugar PD % Oligomer
Lysozyme None None 0
Lysozyme None 0.25mM 0.7
Lysozyme None 2.50mM 0.9
Lysozyme Glucose None 3.4
Lysozyme Glucose 0.25mM 3.0
Lysozyme Glucose 2.50mM 2.3
Lysozyme Fructose None 24.1
Lysozyme Fructose 0.25mM 14.1
Lysozyme Fructose 2.50mM 6.8
Table 8.3: Effect of phenylenediamine (PD) on crosslinking of lysozyme 
(10mg/ml) incubated for 7 days in the absence or presence of 0.1 M sugar in 
0.2M phosphate.
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8.5: Discussion
Acétylation of proteins by acetylsalicylic acid has been reported to have a 
protective effect against glycation in vitro (126, 127). Whether such a protective 
effect occurs in vivo is not yet clear although acetylsalicylic acid feeding has 
been shown to reduce crosslinking of lens crystallins in diabetic rats (132). 
Acétylation may induce a conformational change in the protein structure and 
this might account for the high fluorescence observed with incubations 
containing acetylsalicylic acid (fig 8.1). Furthermore, acetylsalicylic acid may 
itself be fluorescent, and indeed acetylsalicylic acid on its own does fluoresce. 
It is therefore not possible to compare the ability of acetylsalicylic acid to 
reduce sugar-derived fluorescence of lysozyme with the other compounds. Use 
of lower concentrations of acetylsalicylic acid may overcome these problems. 
In an attempt to simulate in vivo conditions, a 200uM concentration of 
acetylsalicylic acid was used and a small inhibitory effect on glucose-derived 
fluorescence of HSA is demonstrable (fig 8.2). A rise in fluorescence of 
albumin incubated in acetylsalicylic acid also occurs but this is probably 
masked by the higher glucose-derived fluorescence. From these in vitro 
studies it seems that levels of acetylsalicylic acid approached in vivo do not 
cause a substantial reduction in glucose-derived protein fluorescence.
Under the conditions used, aminoguanidine proved to be the most effective 
inhibitor of glucose and fructose-derived fluorescence of lysozyme (fig 8.3). 
There are a variety of compounds present in vivo which possess free amino 
groups and such compounds may act in a similar way to aminoguanidine and 
could therefore be used instead of aminoguanidine since they are presumably 
less toxic. For this reason, L-lysine was also included in the study, and 
although an inhibitory effect could be demonstrated (fig 8.4), it was not as
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effective on a molar basis as aminoguanidine. The relative nucleophilicities 
and pK values of amino groups in inhibitors are important and may determine 
their reactivity. The pK of lysine is 10.4 whereas the pK of aminoguanidine 
does not appear to be known. Since aminoguanidine has a similar structure to 
arginine (ie both have a guanidine group), then its pK may be close to that of 
arginine ie 12.5. The chemical structures of lysine and aminoguanidine are
given below;
H
I
H 2N -C -C O O H
lysine aminoguanidine
Aminoguanidine is a hydrazine compound and two of its amino groups are 
chemically more reactive than those of lysine (120) and this probably accounts 
for its greater inhibitory effect.
Free radicals generated by sugar autoxidation have been reported to induce 
fluorescence of proteins (33, 36, 39). To determine whether this free radical- 
derived fluorescence contributes substantially towards the total fluorescence 
generated, a free radical scavenger ie N-acetyl-L-cysteine was also included 
but had the least effect on fluorescence of lysozyme incubated alone or in 
sugars (fig 8.5). These studies therefore suggest that fluorescence changes 
induced by sugars are due to buildup of AGE derived via the Amadori route 
since free radical scavengers appear to have little effect on glucose or fructose- 
derived fluorescence.
Aminoguanidine is also the most effective compound at reducing crosslinking 
of lysozyme (fig 8.6 and table 8.1). In contrast to the inconclusive fluorescence
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studies, here it is clear that acetylsalicylic acid also reduces crosslinking of 
lysozyme but not to the same extent as aminoguanidine. This difference may 
be because aminoguanidine not only inhibits post-Amadori reactions but can 
also react with free carbonyl groups from sugars preventing glycation ie can act 
at more sites than acetylsalicylic acid. It is worth pointing out that amines like 
aminoguanidine could theoretically reduce secondary glycation by reacting 
with free sugars. Decreased secondary glycation of proteins would be 
accompanied by decreased fluorescence and possibly crosslinking, however 
this has yet to be proved. The free radical scavenger N-acetyl-L-cysteine has 
the least effect on sugar-derived crosslinking of lysozyme (fig 8.7 and table 8.1) 
which suggests that free radicals do not have a significant role in sugar- 
induced crosslinking under the conditions used.
A possible explanation for the increase in fluorescence of BSA incubated with 
phenylenediamine is the non covalent binding of the diamine to protein. Such 
binding probably also occurs with glycated BSA but is masked by their greater 
fluorescence. Theoretically phenylenediamine could also react with free 
carbonyl groups from reducing sugars or AP therefore reducing glycation and 
AGE production respectively. However, the compound has no effect on 
glycation of BSA (table 8.2) which suggests that it reacts with post-Amadori 
intermediates ie 3-DG. It is unlikely that the diamine reacts with free carbonyl 
groups from AP since this would affect HCHO release upon periodate 
oxidation, which is not the case. Phenylenediamine also reduces crosslinking 
of lysozyme, particularly when incubated with fructose (table 8.3). Eructation 
induces 3-DG formation almost twice as fast as glucation (155), and since the 
diamine is reacting with these, this may explain its greater inhibitory effect on 
fructose-derived crosslinking.
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CHAPTER 9
Autoxidative Glycation and Protein 
Fragmentation
9.1: Introduction
Exposure of proteins to sugar in vitro for prolonged periods of time results in 
protein crosslinking and fluorescence. Such changes to the protein structure in 
vivo has been implicated in the pathogenesis of diabetic complications. A 
recent hypothesis proposed by Hunt et al suggests that autoxidation of glucose 
catalysed by transition metals generate ketoaldehydes and free radicals which 
contribute towards the changes in protein structure mentioned above (33). 
Furthermore, the hydroxyl radical generated during autoxidative glycation can 
induce protein fragm entation. Hunt et al have dem onstrated such 
fragmentation in vitro by incubating BSA with 25mM glucose in the presence 
and absence of tOOuM Cu^+ (fig 1 of ref (33)). BSA incubated in the absence 
of glucose showed no fragmentation suggesting that the process is sugar- 
induced. Fragmentation of BSA has a specific pattern in that polypeptide 
fragments of 45, 36 and 29KD are produced. Inhibition of glucose-derived 
fragmentation by the metal chelator DETAPAC lead to the suggestion that the 
process is transition metal catalysed.
In the previous chapters, no fragmentation was detectable for BSA, lysozyme 
or RNase on SDS gels. This lack of fragmentation could be due to the fact that 
gels were stained with Coomassie Blue R which may not be sensitive enough 
to detect any fragmentation. Furthermore, all the incubations contained sodium 
azide, a potential free radical scavenger. To see whether fructose and glucose 
can induce protein fragmentation, I used HSA as a model protein and
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incubated it under identical conditions used by Hunt et al (33). Fragmentation 
was examined using silver stained gels to increase sensitivity by a 100 fold. To 
determine whether azide inhibits fragmentation, HSA was incubated in glucose 
in the absence and presence of azide.
Copper ions stimulate protein fragmentation by increasing production of the 
hydroxyl radical responsible for fragmentation (35). Iron will also catalyse 
production of hydroxyl radicals but unlike copper does not bind to albumin. 
Fragmentation of albumin in the presence of copper but not iron will suggest 
that binding of metal to protein may be important for glucose-derived 
fragmentation. Different concentrations of copper and iron were included in 
incubations to see whether there was a dose dependent effect on both 
glucose-derived fragmentation and fluorescence.
9.2: Aims
1: To investigate glucose and fructose-derived fragmentation of HSA
incubated under the identical conditions of Hunt et al.
2: To investigate the effect of different concentrations of copper and iron on
glucose-derived fragmentation of HSA.
3: To investigate the effect of sodium azide on glucose-derived
fragmentation of HSA incubated in the presence or absence of copper or 
iron.
4: To investigate the effect of different concentrations of copper and iron on
glucose-derived fluorescence of HSA.
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9.3: Experimental Protocol
In Vitro Glycation: HSA fatty acid free (1 mg/ml) was incubated in 25mM 
sugar +/- 50-200uM cupric sulphate or iron chloride in 0.1 M potassium 
phosphate buffer, pH 7.4 at 37°C for 8 or 16 days. Incubations contained 3mM 
sodium azide or were performed under sterile conditions (section 2.1). 
Samples were not dialysed.
Detection of Fragmentation: Protein fragmentaion was examined on 10% 
SDS gels after silver staining (section 2.9.2).
Measurement of AGE: Fluorescence was measured as before (section
2.9.1).
Statistical analysis was performed using the Students t test.
9.4: Results
HSA was glycated under the exact conditions used by Hunt et al but no bands 
equivalent to the polypeptide fragments in fig 1 of ref (33) were detectable after 
8 or 16 days of incubation (fig 9.1, lanes A to D)). Similarly incubations with 
fructose do not give rise to any fragmentation products either (fig 9.1 lanes E 
and F).
The protein readily fragments in the presence of 50-200uM copper (lanes B to 
D, fig 9.2). However the fragmentation pattern produced is not like that 
obtained by Hunt et al in that discrete polypeptide fragments ranging from 45- 
29KD are not detectable. Iron appears to have little effect on fragmentation of 
HSA suggesting that binding of the metal to protein may well be required for 
fragmentation (lanes F to H, fig 9.2). Since sodium azide may act as a free 
radical scavenger, the above were repeated in the absence of azide and no 
difference was detectable (fig 9.3) suggesting that azide does not have an 
inhibitory effect on fragmentation.
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The effect of different concentrations of copper on fluorescence of HSA is 
shown in fig 9.4. A significant rise in fluorescence of HSA occurs after addition 
of 50uM copper (p<0.001). Further increases in the levels of copper upto 
200uM result in a significant reduction of fluorescence (p<0.01). In contrast, no 
significant increase in glucose-derived fluorescence of HSA occurs after 
addition of 50uM iron but a significant increase does occur with 100 and 
200uM concentrations of iron (p<0.001) as shown in fig 9.5.
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Fig 9.1 : SDS-PAGE of HSA (1 mg/ml) incubated in the absence of sugar (lanes 
A and B) or in 25mM glucose (lanes C and D) or fructose (lanes E and F) for 8 
and 16 days respectively.
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Fig 9.2: SDS-PAGE of HSA (1 mg/ml) incubated for 8 days in 25mM glucose in 
the presence of azide. The effects of 50uM (lanes B and F), 100uM (lanes C 
and G) and 200uM (lanes D and H) copper and iron respectively are shown.
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Fig 9.3: SDS-PAGE of HSA (1 mg/ml) incubated for 8 days in 25mM glucose in 
the absence of azide. The effects of 50uM (lanes B and F), tOOuM (lanes 0  and 
G) and 200uM (lanes D and H) copper and iron respectively are shown.
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Fig 9.4: Fluorescence of HSA (1 mg/ml) incubated in 25mM glucose (C) for 8 
days in the absence of azide. The effect of different concentrations of copper is 
also shown where Cu 1 is 50uM, Cu 2 is lOOuM and Cu 3 is 200uM. Resuits 
are expressed as mean +/- SD (n=5).
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Fig 9.5: Fluorescence of HSA (Img/ml) incubated in 25mM glucose (C) for 8 
days in the absence of azide. The effect of different concentrations of iron is 
also shown where Fe 1 is 50uM, Fe 2 is lOOuM and Fe 3 is 200uM. Results are 
expressed as mean +/- SD (n=5).
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9.5: Discussion
In an attempt to reproduce the sugar-derived fragmentation pattern of Hunt et 
al, proteins were incubated under the exact conditions used by this group 
except that azide was included to prevent bacterial growth. However, I was 
unable to demonstrate any fragmentation of HSA incubated in glucose or 
fructose in the absence of transition metals (fig 9.1). This finding therefore 
disagrees with that of Hunt et al who demonstrated fragmentation even in the 
absence of transition metals (fig 1, ref (33)). In support of my results other 
workers too have not detected any fragmentation in the absence of transition 
metal ie Sakurai et al (54), Dominiczak, and Kawakishi (personal 
communication).
To demonstrate that the above result was not due to the possible free radical 
scavenging ability of azide, incubations were also performed without azide ie 
under sterile conditions. Glucose-derived fragmentation in the absence of 
transition metals still could not be detected and the azide appeared to have no 
effect (figs 9.2, and 9.3). However fragmentation was readily detectable in 
incubations containing copper and appeared to be in a dose dependent 
manner because careful examination of the gel shows a reduction in intensity 
of the 66KD band for HSA with increasing copper concentrations (fig 9.2). Hunt 
et al produced a specific pattern for BSA fragmentation which was attributed to 
the fact that copper binds to histidine residues in albumin. Autoxidation and 
hydroxyl radical production at these sites may produce the polypeptide 
fragments with molecular weights of 45, 36 and 29KD. However I was unable 
to detect such a specific pattern for fragmentation. Furthermore incubations 
containing iron showed little fragmentation of HSA. This suggests that specific 
binding of the transition metal may be required for oxidative cleavage of the
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protein. Indeed more recent work by Hunt et al shows less than 2% 
fragmentation of lens crystallin (180) compared to over 10% for BSA (33).
Hunt et al have reported that physiological buffers already contain trace 
amounts of transition metals which are in excess of that required to stimulate 
glucose autoxidation and ketoaldehyde production (36). Addition of further 
transition metal did not therefore increase ketoaldehyde production but did 
increase fragmentation (181) since the latter is dependent on hydroxyl radical 
production. A possible explanation for the fragmentation seen by Hunt et al for 
BSA incubated in glucose alone (fig 1 ref (33)) could be contamination of their 
buffers with trace amounts of transition metal sufficient to stimulate glucose 
autoxidation. In support of this is the fluorescence results in fig 9.4 where 
addition of 50uM copper increases fluorescence presumably due to 
ketoaldehyde production since the buffer used in this study may not have 
sufficient transition metal to catalyse glucose autoxidation. In contrast, addition 
of copper in the study by Hunt et al was found to decrease fluorescence of BSA 
and was attributed to degradation of ketoaldehydes by excess transition metals 
thus lowering their steady state levels (33). Further increase in copper (200uM) 
also decreased fluorescence in this study (fig 9.4). Addition of iron however 
increases fluorescence in a dose dependent manner (fig 9.5).
From the above studies it appears that glucose autoxidation catalysed by 
copper does induce protein fragmentation. Plasma copper levels do rise during 
diabetes probably by an increase in ceruloplasmin, but even then whether 
these levels are sufficient to catalyse significant sugar-induced fragmentation is 
not yet known. Furthermore, sugar-induced fragmentation may not be a 
significant process in vivo since binding of copper is restricted to a limited 
number of proteins. To my knowledge there is no evidence at present to
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suggest that fragmentation of proteins susceptible to diabetic complications 
does occur in vivo.
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CHAPTER 10
Overall Observations
10.1; Overall Discussion
The purpose of this chapter is to summarise and provide an overview of the 
work done in this thesis and to see how the individual topics interrelate with 
each other ie the experimental work will be considered as a whole rather than 
a series of individual topics.
In recent years glycation and the Maillard reaction have received considerable 
interest because of their possible role in the secondary complications of 
diabetes and ageing. These secondary complications are a major cause of 
morbidity and mortality in diabetics and the elderly and this justifies the 
continuous research into glycation. However, research in this field has been 
hampered due to several reasons. Not least is the lack of specific, sensitive 
and reproducible assays for quantifying glycation and Maillard products. Of the 
simple assays for glycation, the periodate assay of Gallop et al has the 
advantage in that it is stoichiometric, suitable for absolute values and can be 
used on intact proteins (43). In this work the method of Gallop et al has been 
modified and adapted for use with a microplate reader. This microassay has 
the advantage in that it is faster, more sensitive and has an improved yield of 
DDL. A major disadvantage of the periodate method is that collagen crosslinks 
interfere and so the assay is unsuitable for measuring glycated collagen. 
Although collagen was not investigated in this study, a microassay for glycated 
collagen was developed based on the TBA method of Parker et al (144). This 
TBA microassay is more sensitive, faster, less cumbersome than the Parker 
method and is suitable as a rapid assay for measuring glycated collagen. An
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excellent correlation coefficient of 0.94 was obtained between the periodate 
microassay and the more established TBA method.
Almost all the glycation assays are designed to detect the glucose-derived AP 
because in vivo most proteins are likely to be glycated by this sugar. However 
glycation by other sugars, notably fructose is also possible, particularly during 
diabetes. I have confirmed that fructose-induced changes to protein structure 
occur considerably faster than those induced by glucose on a molar basis yet 
apparent AP levels measured by the periodate microassay for fructated BSA 
were consistently lower than those for g located BSA. It is possible to account 
for this by considering the underlying chemistry of the assay and the nature of 
the fructose-derived AP. The highly reactive aldehydic AP derived during 
fructation is unlikely to release HCHO during periodate oxidation and so the 
true extent of fructation may be underestimated by this assay. Furthermore, it 
appears that this is true for other methods such as the TBA, fructosamine and 
phenylboronate assays (chapter 5, table 5.1). It can be argued that faster 
conversion of fructose-derived AP to AGE may be responsible for the apparent 
low levels of AP observed in fructated proteins when compared to g located 
proteins. However ribose induces AGE formation considerably faster than 
fructose for albumin yet also has higher AP levels when measured by the 
periodate microassay (chapter 4, fig 4.1). It therefore seems that the true extent 
of protein damage by fructose may be underestimated by assays which 
measure the AP only. In contrast methods which measure the rate of SB and 
AGE formation clearly suggest the greater hazards of any in vivo fructation. A 
common feature of all AP is the possession of a carbonyl group and an assay 
which measures these may provide a better estimation of glycation. For this 
reason the DNPH assay was developed and the levels of protein bound 
carbonyl groups for fructated albumin were found to be considerably higher
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than those for the corresponding glucated sample (chapter 5, fig 5.5). 
Therefore the DNPH assay gives a more accurate measure of fructose-derived 
changes to protein structure than any of the other assays used. This work has 
therefore revealed the inadequacies in present glycation assays and improved 
assays for glycation by both glucose and fructose have been developed.
At present there are hardly any simple, specific assays for AGE since very little 
information is available regarding their structure. The limited information 
available suggests that there are different types of AGE and methods used to 
quantify the few that have been characterised are available only in certain 
laboratories. In this study AGE were measured by their fluorescence and 
crosslinking properties. These procedures are not very specific because 
fluorescence and crosslinking of proteins can be caused by other processes 
notably free radicals and lipid peroxidation products (reviewed in (182)).
In vitro studies using radiolabelled sugars have demonstrated that nearly all 
the monosaccharides form the SB faster than glucose (11) and in vivo the low 
levels of these sugars could be compensated for by their greater reactivity. In 
this study the effect of different sugars on fluorescence formation was studied 
and it was found that ribose, fuctose and galactose induced fluorescence faster 
than glucose on a molar basis irrespective of the protein used (chapter 4, figs 
4.2, 4.4 and 4.5). These comparative fluorescence studies are consistent with 
the comparative rates of SB formation ie of the four sugars used ribose, which 
would be expected to have the fastest rate of SB formation, was also found to 
have the fastest rate of fluorescence formation.
This thesis has also shed light on the mechanisms involved in AGE formation. 
Previous work has suggested that sugar-derived fluorescent products are 
formed by reaction between (i) two AP's, (ii) 3-DG and free amino groups or (iii)
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3-DG and AP's. These products may or may not be crosslinks but are all 
believed to be fluorescent. In this study evidence has been presented for a 
possible reaction between the secondary amino group on AP and free sugars 
to produce fluorescent products. Whether these products give rise to crosslinks 
has not yet been determined. Furthermore, fluorescent products formed by 
secondary glycation depend on the reactivity of the glycating sugar, hence 
fructose induces secondary glycation faster than glucose. That secondary 
glycation is a significant process for fluorescence generation can be 
demonstrated by reincubating glycated proteins in the absence of sugar. 
Hardly any further increase in fluorescence is detectable in fructated BSA 
(chapter 6, fig 6.5) and only a small increase occurs in glucated BSA (chapter 
6, fig 6.4). This small rise in fluorescence of glucated BSA incubated in the 
absence of sugar could be due to production of 3-DG from AP which then react a, 
with free amino groups to form protein bound pyrroles. This mechanism has ; 
been proposed for the formation of pyrraline (20). It is noteworthy that RM- 
glucated BSA reincubated in the absence of sugar does not show a further 
increase in fluorescence presumably because the amino groups are blocked 
and therefore not available for pyrrole formation (chapter 7, fig 7.1). In the case 
of fructated BSA, conversion of AP to AGE occurs so rapidly that the reaction 
may have already gone to completion and this may account for the lack of 
increase in fluorescence generated by fructated BSA upon reincubation in the 
absence of sugar. Another study by McPherson et al demonstrated a rise in 
fluorescence of both glucated and fructated RNase upon reincubation after 
removal of sugars (57). However these workers used a rapid procedure for . 
removal of unbound sugar unlike the extensive dialysis over a period of 3-4 
days used in this study.
Page 193
Phosphate may catalyse conversion of AP to AGE since the rise in 
fluorescence of glucated BSA after removal of sugars only occurs in phosphate 
and not HEPES buffer. Phosphate is believed to increase percentage sugar in 
the acyclic form (165) and a similar effect on AP's which largely exist in the 
cyclic form may account for the rise in fluorescence of glucated BSA 
reincubated in phosphate buffer after removal of free sugars. In this study the 
fluorescence of glucated BSA reincubated in the absence of sugar also 
increased with pH. Like phosphate an increase in pH can also increase the 
percentage sugar in acyclic form (163) and a similar effect on the AP may 
account for the rise in fluorescence of glucated BSA. However this is mere 
speculation and as far as I know there is no information on the effect of pH or 
phosphate on the percentage of AP in acyclic form. Previous studies have 
shown that a rise in both phosphate (164) and pH (41) can increase the extent 
of glycation. In this study, phosphate and pH were found to increase 
fluorescence of both glucated and fructated BSA. This effect is mediated partly 
by increased glycation and probably increased secondary glycation as well.
Previous studies have shown that less than 1% of crosslinks in glucated 
lysozyme are fluorescent and the pathways for fluorescent and non-fluorescent 
crosslinks may operate independently of each other (26). Using equimolar 
concentrations of lysozyme and RNase incubated in ribose, I was able to show 
that RNase generates fluorescence considerably faster than lysozyme (chapter 
4, fig 4.6) whereas the latter crosslinked slightly faster (chapter 4, fig 4.9). 
Furthermore the comparative rates of crosslinking by different sugars for 
lysozyme and RNase were not consistent with their comparative rates for 
fluorescence or SB formation. In this case it was found that fructose-derived 
crosslinking of RNase occurred almost as fast as that derived by ribose
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whereas for lysozyme, fructose-derived crosslinking was actually faster than 
that induced by ribose. In contrast to the fluorescence studies for reincubated 
glucated BSA, no increase in crosslinking of fructated or glucated lysozyme 
was detectable after reincubation in the absence of sugar. The two studies 
which have demonstrated increased crosslinking of glycated proteins after 
removal of free sugars used RNase (55, 57), and to my knowledge this effect 
has not been demonstrated for other proteins.
Based on the studies of Eble et al (55) and McPherson et al (57) it is believed 
that once a protein is glycated it will continue to form AGE albeit at an 
accelerated rate even after removal of sugar. This is thought to be because the 
AP is no longer competing with free sugar carbonyls in order to react with 
protein amino groups. This finding has been used to explain why certain 
diabetic complications progress even after strict metabolic control, For eg it has 
been reported that diabetic retinopathy continues to progress in patients whose 
glycaemia is normalised after a successful pancreas transplantation (183). 
However the results in this study support those of Schleicher et al (90) and 
Kato et al (172) who too could not detect any appreciable rise in fluorescence 
of albumin after exhaustive removal of sugars, Using glycated lysozyme, no 
further rise in crosslinking was detectable after removal of free sugars. In 
contrast to the clinical studies above, there are other studies which have shown 
that strict metabolic control can reverse progression of certain diabetic 
complications. For eg strict metabolic control has been shown to reduce 
thickening of basement membranes (184) in diabetics and an improvement in 
diabetic neuropathy (185). These findings can be used to reiterate the 
importance of maintaining normoglycaemia in an attempt to reduce the risk of 
development and progression of diabetic complications.
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An alternative to strict metabolic control would be to use drugs which could 
reduce glycation and AGE formation in vivo. In this respect aminoguanidine 
has received considerable interest as a possible inhibitor of AGE formation in 
vivo and at present is undergoing toxicity studies (120). In this study 
aminoguanidine proved to be the most effective inhibitor of glucose and 
fructose-derived fluorescence and crosslinking of lysozyme when compared on 
a molar basis with acetylsalicylic acid, L-lysihe and N-acetyl-L-cysteine. A 
possible reason for this could be because it can act at more sites in the 
pathway for AGE formation. L-lysine may also act at these sites but is not as 
effective as aminoguanidine because of the lower reactivity of its amino 
groups.
In this study, phenylenediamine was used to inhibit glucose (chapter 8, fig 8.8) 
and fructose-derived fluorescence of BSA (chapter 8, fig 8.9). Similarly 
phenylenediamine inhibited glucose and fructose-derived crosslinking of 
lysozyme in a dose dependent manner. This compound probably reacts with 3- 
DG since it has no effect on glycation (chapter 8, table 8.2).
For a substance to be of any use as a inhibitor of glycation and AGE formation 
in vivo, it should have a long half life because glycation is a spontaneous 
reaction and occurs all the time. Furthermore the substance should have 
virtually no toxicity since it will probably have to be administered for long 
periods of time. Obviously all these requirements are not easy to fulfill and in 
my opinion it seems unlikely that administration of antiglycation or anti-AGE 
compounds will be of use in vivo for the prevention of diabetic complications.
A recent hypothesis proposed by Hunt et al has questioned whether the 
fluorescence and crosslinking changes produced during incubation of proteins 
in sugars is due solely to post-Amadori reactions (33). This group has
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suggested that autoxidation of sugars may occur to produce reactive 
dicarbonyl compounds and free radicals which can cause protein fluorescence 
and crosslinking. Changes to protein structure as a result of autoxidative 
glycation are similar to those derived by glycation and it is very difficult to 
distinguish between the two. However the hydroxyl radical produced during 
autoxidative glycation can cause fragmentation of proteins. In this study, no 
evidence for fragmentation was seen even after using the exact conditions of 
Hunt et al (33). It was however possible to induce fragmentation by using 
copper which suggests that transition metals are required for autoxidative 
glycation. Furthermore binding of transition metal to protein is important since 
little fragmentation was detectable for HSA incubated in iron. The free radical 
scavenger N-acetyl-L-cysteine appeared to have little effect on fluorescence 
(chapter 8, fig 8.5) and crosslinking (chapter 8, table 8.1) of lysozyme 
suggesting that under the conditions used, sugar-derived free radicals!do not 
contribute significantly towards these changes.
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Suggestions for Further Study
If time permitted I would have liked to extend aspects of the work covered in
this thesis. There are 4 major areas which merit further investigation;
1: The DNPH microassay used in this work gives higher values for protein
bound carbonyl groups in fructated compared to glucated BSA. However 
it is not yet clear whether the majority of these carbonyl groups are from 
AP or AGE. Periodate treatment of proteins will selectively remove AP 
without affecting AGE (99). Values for protein bound carbonyl groups in 
fructated proteins before and after periodate oxidation should yield useful 
information regarding the contribution of AP carbonyl groups.
2: Studies in this work on fluorescence and crosslinking of glycated proteins
after removal of free sugars were complicated by the long periods of 
dialysis prior to reincubation. These experiments could be repeated using 
a rapid method for removal of unbound sugar such as Sephadex G-25 
columns.
3; The possibility of fluorophores being generated as a result of secondary
glycation has been demonstrated in this work. However it is not known 
whether these secondary glycation products are also crosslinks. This 
work can therefore be repeated and crosslinking of the secondary 
glycated protein can be examined on SDS gels. The possibility that 
aminoguanidine may reduce fluorescence and crosslinking by inhibiting 
secondary glycation can also be investigated by including this compound 
in the incubations.
4: The secondary glycation products are believed to be pyrroles in nature
and to confirm whether this is true, the method of Scott et al based on the
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Ehrlichs reagent (174) could be used to assay for protein bound pyrroles 
in secondary glycated proteins.
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